data_2l0m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l0m _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.837 0.351 . . . . 45.53 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 tp -63.39 -27.14 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.133 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 7.95 18.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 75.14 110.889 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.42 -38.24 4.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 65.41 110.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -14.28 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.875 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 -43.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.085 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.01 46.25 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.095 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.85 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 71.42 110.897 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -12.38 43.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.881 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.31 4.42 4.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 70.5 112.468 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.49 -25.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 55.43 111.107 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.7 mt -81.59 0.1 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.31 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.1 -21.15 16.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 71.33 112.476 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.74 -12.35 15.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 74.51 111.094 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.29 -43.6 12.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 63.22 111.131 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.43 -22.71 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.54 110.933 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 61.21 111.159 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.843 0.354 . . . . 64.5 110.827 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.52 -27.73 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 73.2 111.124 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 9.75 18.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.918 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.43 -40.18 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 64.25 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.84 -14.95 40.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.864 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.4 -42.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 74.02 111.122 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.48 44.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 71.42 111.077 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.24 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.953 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.32 -12.27 43.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.883 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.27 4.41 4.13 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.44 112.462 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -101.64 -25.07 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.879 0.371 . . . . 72.33 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.66 0.16 39.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.911 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.18 -21.16 17.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.759 . . . . 70.33 112.472 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.96 -11.69 15.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 53.24 111.106 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.02 -42.79 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 73.1 111.071 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.42 -22.35 28.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 75.21 110.935 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.05 111.154 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.886 0.374 . . . . 71.24 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.88 -27.32 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 72.21 111.145 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -113.56 10.87 18.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 74.02 110.949 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -38.94 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 75.3 110.89 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -14.02 42.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.866 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -113.14 -43.58 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.3 111.14 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.04 45.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.21 111.1 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.86 -32.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 65.33 110.975 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -11.9 42.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.79 4.86 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 61.01 112.468 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.65 -24.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 72.43 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 0.25 39.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.51 -20.17 22.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 71.42 112.46 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.15 -0.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 73.3 111.098 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.77 -40.9 9.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 73.42 111.151 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -23.42 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.919 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.2 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 71.11 111.159 179.826 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.898 0.38 . . . . 72.43 110.906 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -63.36 -27.26 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 74.32 111.146 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.66 8.67 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.902 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.27 -38.84 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 61.22 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.18 -13.54 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.3 110.863 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.84 -44.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.126 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.02 45.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 70.14 111.077 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.61 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.893 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -11.5 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.913 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.55 0.64 5.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 61.0 112.506 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.84 -24.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 74.43 111.113 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mt -81.19 -0.1 38.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 74.34 110.914 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.91 -21.37 16.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 64.41 112.478 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.14 -12.08 15.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.52 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.7 -42.97 12.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 64.5 111.074 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.09 -22.4 28.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 73.21 110.937 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.0 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.41 111.158 179.85 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.831 0.348 . . . . 74.55 110.846 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -26.56 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.154 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.24 8.37 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.918 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.36 -37.79 4.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 75.35 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -89.23 -14.68 35.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.855 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.04 -41.97 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 74.44 111.119 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.68 45.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.122 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.73 -32.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 75.12 110.961 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -13.55 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.863 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -3.4 5.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 75.03 112.447 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.82 -38.64 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 72.43 111.158 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.15 0.74 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 70.33 110.914 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.37 -20.92 18.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 64.04 112.49 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.5 -15.41 15.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 73.24 111.114 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.52 -42.43 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 75.22 111.108 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -23.02 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 54.22 110.952 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.074 179.863 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.839 0.352 . . . . 71.22 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.87 -26.84 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 75.45 111.204 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.53 8.24 13.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 75.52 110.914 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.84 -37.22 4.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.904 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.96 -14.98 32.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.858 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.79 -41.42 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.23 111.141 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.82 46.14 1.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.23 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.94 -32.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.921 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -13.39 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 71.3 110.885 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.69 3.79 4.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 74.0 112.474 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -101.21 -25.97 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 71.22 111.099 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.4 -1.07 39.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.904 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.45 -21.02 18.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 75.14 112.525 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.83 5.18 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 70.13 111.11 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.99 -41.29 7.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 70.33 111.099 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.45 -19.51 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 71.34 110.938 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.14 111.123 179.858 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.844 0.354 . . . . 72.11 110.84 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.63 -26.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.146 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.97 7.08 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 74.42 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -37.38 5.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -89.04 -15.96 32.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.841 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 t -113.33 -41.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.146 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.65 39.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.34 111.119 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.05 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.37 -12.84 56.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.877 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.81 4.91 4.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.71 -0.757 . . . . 64.44 112.467 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.8 -25.34 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 72.21 111.123 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.88 0.4 39.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.905 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.31 -21.08 18.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 73.33 112.506 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.18 -12.52 15.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.2 111.126 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 -41.59 12.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 54.53 111.068 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.48 -18.78 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.926 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.25 111.128 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 75.3 110.867 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -62.18 -26.96 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 73.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 10.94 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.936 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -116.62 -39.01 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 70.31 110.897 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.99 -13.82 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.882 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.75 -43.28 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.3 111.108 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.22 46.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.109 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.91 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.45 110.906 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -12.65 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 60.45 110.87 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.04 4.1 4.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 70.42 112.478 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.1 t -101.05 -25.03 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 74.01 111.124 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -81.65 0.19 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 63.31 110.939 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.12 -21.18 17.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 45.31 112.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.76 -12.26 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 63.34 111.082 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.47 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.13 111.118 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.58 -22.68 29.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 73.34 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 73.42 111.145 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.8 0.333 . . . . 53.25 110.835 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 tp -55.18 -29.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.146 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -114.37 12.29 17.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 73.44 110.916 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -114.16 -38.66 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.858 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -90.84 -14.41 31.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.877 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.37 -40.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.126 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.33 45.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 64.33 111.118 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.24 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.848 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -14.76 27.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 64.32 110.912 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -5.15 5.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.735 -0.745 . . . . 64.03 112.508 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 73.1 111.119 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.16 0.6 40.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.897 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.44 -20.8 18.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 53.35 112.516 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.09 -12.83 15.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 72.22 111.084 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.27 -41.47 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 70.11 111.109 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.4 -18.89 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 73.23 110.877 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.3 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 74.51 111.138 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.905 0.383 . . . . 73.4 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.92 1.33 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 75.12 111.185 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.61 -32.11 4.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 75.52 110.947 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -96.14 -3.74 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 62.34 110.873 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -100.11 -19.38 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.91 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -121.39 -41.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.109 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.69 42.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 73.42 111.106 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tt -172.94 -35.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 73.14 110.916 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -86.21 -14.2 44.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.901 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -127.91 -3.37 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.445 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.7 t -87.64 -37.87 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 74.14 111.13 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -81.32 -0.03 39.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.4 -20.02 20.82 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 75.22 112.494 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.05 -1.09 13.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 72.25 111.101 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.78 -40.69 9.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.16 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -23.5 16.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.941 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.119 179.86 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 72.2 110.852 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 tp -52.98 -29.25 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.12 111.1 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -32.31 58.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.9 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.2 -21.5 29.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.34 110.88 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -91.07 -5.41 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.893 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.67 -51.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.165 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.82 46.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 73.14 111.063 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.24 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 75.13 110.95 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -93.2 -11.75 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.909 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.29 -0.71 5.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.508 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -23.32 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 72.12 111.164 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.91 -0.31 38.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 73.42 110.889 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.08 -20.41 20.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 73.13 112.52 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.64 -0.42 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 71.35 111.13 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.67 -40.74 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 70.11 111.099 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -20.71 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 70.23 110.927 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.43 111.172 179.793 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 72.11 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -54.14 -44.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 70.34 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.89 -1.26 42.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.862 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.45 -33.13 10.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 72.23 110.862 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.63 -12.56 45.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.872 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.28 -47.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.086 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.91 45.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.22 111.127 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.98 -32.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.23 110.91 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.51 -10.84 39.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.847 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.01 0.4 5.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 74.33 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.65 -20.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 73.25 111.162 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.79 -1.97 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.928 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.54 -19.63 20.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 74.55 112.501 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.58 -1.46 14.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.813 0.34 . . . . 65.11 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.15 -39.72 9.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 70.44 111.151 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.36 -23.89 15.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.923 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.155 179.787 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.848 0.356 . . . . 75.44 110.836 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.95 -23.83 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.21 111.175 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -112.57 -23.13 10.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.923 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.28 -27.28 47.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 70.53 110.927 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -83.55 -44.44 14.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 75.14 110.896 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.9 t -50.94 -27.35 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.2 111.092 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.0 31.94 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.072 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.72 -34.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.3 110.899 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -16.94 56.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.925 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.24 2.24 4.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.81 -0.71 . . . . 71.33 112.503 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.92 -25.15 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 71.34 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.7 mt -81.87 0.46 39.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 75.33 110.91 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.93 -19.43 22.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.46 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.55 1.07 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.304 . . . . 74.32 111.083 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.8 -42.53 8.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.21 111.081 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.92 -22.2 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 73.31 110.941 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.5 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.121 179.8 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.823 0.344 . . . . 64.34 110.825 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.38 -27.15 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.177 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.64 8.32 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 64.21 110.946 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.87 -38.6 4.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 65.13 110.875 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -87.12 -13.92 42.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 72.02 110.882 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.62 -43.96 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.24 111.156 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.28 45.42 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 75.54 111.068 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.91 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.94 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -11.45 39.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.04 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.25 -0.41 5.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 71.22 112.473 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.43 -19.83 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 74.11 111.114 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.55 -1.89 34.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.67 -19.47 20.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 73.45 112.517 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.43 -1.43 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 73.43 111.128 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.7 -39.04 10.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 64.42 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.42 -21.35 17.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.918 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 64.22 111.139 179.805 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.9 0.381 . . . . 74.34 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.85 -27.81 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 74.32 111.119 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.06 12.79 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.892 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.53 -40.39 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 71.12 110.871 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.28 -12.8 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.833 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.98 -43.95 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.2 111.119 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.69 44.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 62.53 111.085 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.64 -31.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.906 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -11.54 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.897 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.09 -18.16 8.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 63.53 112.494 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.6 t -87.4 -66.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 63.3 111.118 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt 45.98 30.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.921 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.71 29.24 18.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.498 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.61 -74.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 63.13 111.094 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.21 -52.25 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.078 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -28.45 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.942 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 72.3 111.121 179.843 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.876 0.37 . . . . 74.51 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.22 -27.29 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 70.51 111.143 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.01 10.06 11.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.912 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -32.14 6.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 70.42 110.891 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 74.4 110.91 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.1 t -112.73 -36.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.3 111.128 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.94 45.48 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.076 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -32.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.66 -15.31 42.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 62.04 110.902 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.78 2.82 4.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 62.04 112.477 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.77 -24.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 74.4 111.101 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.67 0.22 39.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.899 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.5 -20.11 21.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 74.12 112.465 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.38 -0.5 13.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 75.42 111.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.02 -40.96 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 63.43 111.091 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -23.33 16.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 64.22 110.937 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.52 111.141 179.855 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.84 0.352 . . . . 73.34 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.17 0.53 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.32 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -116.91 -24.36 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.3 110.91 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -26.17 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 74.41 110.851 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.49 -14.22 38.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.863 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.7 -49.53 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.15 111.074 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.82 46.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.077 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.34 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 71.34 110.935 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -11.08 33.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.11 110.899 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.66 0.87 5.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 61.14 112.523 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.08 -23.65 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 73.21 111.143 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -82.04 0.89 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.958 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.77 -19.45 21.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.753 -0.737 . . . . 71.54 112.527 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.85 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.743 0.306 . . . . 74.02 111.097 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -44.5 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.13 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.05 -20.23 42.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.914 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.43 111.126 179.836 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.836 0.35 . . . . 74.23 110.816 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 tp -53.33 -29.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.41 111.117 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.46 -10.87 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 74.32 110.941 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -27.41 22.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 70.3 110.91 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -41.98 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.856 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -55.51 -22.52 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -8.36 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 tp -134.91 -32.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.927 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -88.74 -18.11 28.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.15 110.87 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.83 -17.98 4.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 64.41 112.48 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.93 -24.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 63.32 111.128 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.4 -1.23 39.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.931 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.95 -20.05 17.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 54.32 112.485 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.78 -12.28 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 52.23 111.073 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.69 -42.82 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.069 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -84.9 -22.32 29.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 63.5 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.15 111.134 179.855 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 75.12 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.67 -1.55 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 75.21 111.115 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -108.49 -25.97 10.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.893 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -92.14 -21.98 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 74.12 110.937 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -88.24 -13.37 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.85 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.9 -52.74 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.139 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.92 48.13 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.22 111.07 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.66 -32.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -10.75 40.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.92 0.31 5.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 74.25 112.461 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -89.44 -19.83 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 71.23 111.097 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.71 0.65 39.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.885 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.64 -17.35 26.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 75.33 112.467 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.86 -9.84 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 75.34 111.085 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 -44.31 8.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.108 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 pp -79.77 -23.6 42.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.918 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.117 179.871 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.881 0.372 . . . . 61.1 110.867 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.78 4.26 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.31 111.12 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -116.41 -27.14 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.11 110.911 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.16 -24.42 18.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 74.42 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -90.97 -6.62 53.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.54 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.33 -50.37 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.12 111.11 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.1 45.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.43 111.08 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -173.56 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.14 110.896 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.64 -11.09 56.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.869 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.93 6.0 3.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 74.01 112.501 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.42 -25.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 71.34 111.117 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -81.97 0.54 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.01 110.916 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.25 -21.08 17.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 72.03 112.472 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.88 -14.12 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 73.53 111.102 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.19 -43.22 13.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.52 111.104 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 -22.87 31.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.917 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 73.32 111.125 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.802 0.334 . . . . 72.44 110.933 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -172.05 152.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.52 110.91 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.19 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 65.3 110.908 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -54.09 -33.8 58.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 45.53 110.846 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 tp -63.39 -27.14 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 71.43 111.133 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.64 7.95 18.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 75.14 110.889 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.42 -38.24 4.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 65.41 110.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -87.24 -14.28 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.875 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.06 -43.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 71.41 111.085 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.01 46.25 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.095 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.85 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 71.42 110.897 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -12.38 43.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.881 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.31 4.42 4.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 70.5 112.468 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.49 -25.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 55.43 111.107 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.7 mt -81.59 0.1 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.31 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.1 -21.15 16.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 71.33 112.476 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.74 -12.35 15.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 74.51 111.094 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.29 -43.6 12.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 63.22 111.131 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.43 -22.71 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.54 110.933 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mm -100.35 -19.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 61.21 111.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.24 18.44 51.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.757 . . . . 75.11 112.463 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.96 -74.09 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.716 0.293 . . . . 74.23 111.109 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -57.48 -28.38 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 75.43 111.118 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.87 73.64 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 65.31 111.064 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.87 15.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.627 2.218 . . . . 73.04 112.322 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 23.01 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 71.33 110.906 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.883 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.847 0.356 . . . . 73.55 110.87 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -168.21 144.11 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 75.42 110.848 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.18 -63.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.947 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -53.56 -33.4 54.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 64.5 110.827 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.52 -27.73 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 73.2 111.124 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -113.22 9.75 18.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.918 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.43 -40.18 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 64.25 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.84 -14.95 40.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.42 110.864 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.8 t -113.4 -42.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 74.02 111.122 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.48 44.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 71.42 111.077 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.24 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.953 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.32 -12.27 43.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.883 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.27 4.41 4.13 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.44 112.462 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -101.64 -25.07 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.879 0.371 . . . . 72.33 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.66 0.16 39.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 73.32 110.911 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.18 -21.16 17.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.759 . . . . 70.33 112.472 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.96 -11.69 15.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 53.24 111.106 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.02 -42.79 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 73.1 111.071 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.42 -22.35 28.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 75.21 110.935 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -101.1 -19.98 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.05 111.154 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.14 18.43 51.53 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 70.44 112.487 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.22 -66.21 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 70.44 111.066 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.3 -37.82 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 75.03 111.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.64 70.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.579 0.704 . . . . 74.54 111.122 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -27.59 26.43 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.268 . . . . 74.31 112.363 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.74 23.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 72.25 110.902 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.1 110.904 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.823 0.344 . . . . 72.15 110.931 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 154.7 47.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 73.33 110.934 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.17 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 75.4 110.893 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -53.89 -34.11 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 71.24 110.882 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 tp -62.88 -27.32 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 72.21 111.145 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 43.2 m-85 -113.56 10.87 18.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 74.02 110.949 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -38.94 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 75.3 110.89 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -14.02 42.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.866 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -113.14 -43.58 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 74.3 111.14 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.04 45.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.21 111.1 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.86 -32.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 65.33 110.975 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -11.9 42.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 73.33 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.79 4.86 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 61.01 112.468 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.65 -24.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 72.43 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 0.25 39.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 73.43 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.51 -20.17 22.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 71.42 112.46 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.15 -0.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 73.3 111.098 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.77 -40.9 9.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 73.42 111.151 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -23.42 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 75.24 110.919 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.2 mt -116.99 -21.42 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 71.11 111.159 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.38 19.59 46.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 62.03 112.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.93 -67.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 72.33 111.117 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 pt -52.53 -29.11 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.22 111.156 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.82 74.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.571 0.701 . . . . 72.11 111.081 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.76 -43.29 2.74 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.673 2.249 . . . . 75.13 112.39 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.6 24.36 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 71.44 110.89 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.925 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.845 0.355 . . . . 74.14 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -173.22 159.51 3.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 74.25 110.949 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.25 -74.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.14 110.89 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.99 -33.92 58.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 72.43 110.906 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -63.36 -27.26 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 74.32 111.146 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -112.66 8.67 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 73.02 110.902 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.27 -38.84 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 61.22 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.18 -13.54 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.3 110.863 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -113.84 -44.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 75.34 111.126 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -91.02 45.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 70.14 111.077 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.61 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 72.13 110.893 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -11.5 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.913 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.55 0.64 5.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 61.0 112.506 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.84 -24.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 74.43 111.113 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.6 mt -81.19 -0.1 38.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 74.34 110.914 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.91 -21.37 16.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 64.41 112.478 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.14 -12.08 15.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.52 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.7 -42.97 12.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 64.5 111.074 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.09 -22.4 28.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 73.21 110.937 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.0 mt -101.16 -18.33 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 74.41 111.158 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.03 25.78 18.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 74.04 112.459 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.5 -55.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 73.24 111.088 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -52.01 -29.55 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 71.13 111.125 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.74 74.31 0.47 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.71 . . . . 73.33 111.094 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.76 -16.67 37.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 74.3 112.335 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.75 -33.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.03 110.896 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 72.21 110.927 179.859 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.821 0.343 . . . . 75.44 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -146.55 107.65 4.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 73.15 110.948 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -75.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 63.21 110.931 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -28.84 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.846 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -61.3 -26.56 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 75.33 111.154 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -116.24 8.37 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.918 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.36 -37.79 4.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 75.35 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.9 ptt85 -89.23 -14.68 35.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 72.53 110.855 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -113.04 -41.97 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 74.44 111.119 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.68 45.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.122 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.73 -32.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 75.12 110.961 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -13.55 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 71.23 110.863 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -3.4 5.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 75.03 112.447 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.82 -38.64 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 72.43 111.158 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -82.15 0.74 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 70.33 110.914 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.37 -20.92 18.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 64.04 112.49 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.5 -15.41 15.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 73.24 111.114 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.52 -42.43 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 75.22 111.108 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -83.78 -23.02 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 54.22 110.952 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -104.09 -15.03 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.074 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.35 -21.97 35.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 74.42 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.75 47.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 75.42 111.123 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm 51.64 47.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 70.2 111.147 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.63 74.06 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.596 0.712 . . . . 54.33 111.113 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -29.0 24.46 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 75.21 112.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 23.09 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.1 110.895 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mmtt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 74.01 110.926 179.853 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.9 mttm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 75.44 110.922 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 125.17 42.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.931 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.37 -67.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.901 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -62.79 -28.51 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 71.22 110.847 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.87 -26.84 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 75.45 111.204 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -116.53 8.24 13.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 75.52 110.914 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.84 -37.22 4.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.42 110.904 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -89.96 -14.98 32.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.858 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -112.79 -41.42 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.23 111.141 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -96.82 46.14 1.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.23 111.125 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.94 -32.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 74.33 110.921 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -13.39 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 71.3 110.885 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.69 3.79 4.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 74.0 112.474 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -101.21 -25.97 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 71.22 111.099 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.4 -1.07 39.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.904 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.45 -21.02 18.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 75.14 112.525 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.83 5.18 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 70.13 111.11 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.99 -41.29 7.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 70.33 111.099 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.45 -19.51 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 71.34 110.938 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 17.6 mt -119.65 -6.55 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.14 111.123 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.15 -27.46 23.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 52.11 112.469 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.33 40.62 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 72.24 111.09 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm 51.7 44.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 63.3 111.141 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.46 74.23 0.83 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 73.0 111.073 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -48.49 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.272 . . . . 72.34 112.336 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.95 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 75.23 110.896 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 75.13 110.916 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.5 mttm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.898 0.38 . . . . 73.24 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.65 99.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.873 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.76 -75.31 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 64.11 110.929 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -55.3 -28.47 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 72.11 110.84 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.63 -26.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.146 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -115.97 7.08 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 74.42 110.931 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -37.38 5.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -89.04 -15.96 32.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 75.12 110.841 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.6 t -113.33 -41.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.33 111.146 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.65 39.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 72.34 111.119 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -172.05 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 75.41 110.906 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.37 -12.84 56.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 74.32 110.877 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.81 4.91 4.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.71 -0.757 . . . . 64.44 112.467 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.8 -25.34 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 72.21 111.123 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.88 0.4 39.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.905 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.31 -21.08 18.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 73.33 112.506 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.18 -12.52 15.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.2 111.126 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 -41.59 12.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 54.53 111.068 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.48 -18.78 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.926 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.0 mm -105.59 -20.64 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 71.25 111.128 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.71 20.13 43.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.762 . . . . 75.34 112.45 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.83 -49.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 54.41 111.116 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.6 -31.45 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 75.51 111.129 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 52.69 71.62 1.4 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.55 0.691 . . . . 73.13 111.059 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.77 -16.89 37.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.247 . . . . 72.11 112.336 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.83 -33.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.896 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 74.33 110.909 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.866 0.365 . . . . 63.25 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -111.85 133.98 53.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 75.23 110.904 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.22 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 72.03 110.903 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.97 -32.49 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.867 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -62.18 -26.96 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 73.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 10.94 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.936 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -116.62 -39.01 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 70.31 110.897 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -87.99 -13.82 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 74.33 110.882 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.1 t -112.75 -43.28 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 75.3 111.108 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.22 46.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.109 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.91 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.45 110.906 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -12.65 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 60.45 110.87 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.04 4.1 4.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 70.42 112.478 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.1 t -101.05 -25.03 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 74.01 111.124 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -81.65 0.19 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 63.31 110.939 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.12 -21.18 17.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 45.31 112.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.76 -12.26 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 63.34 111.082 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.47 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.13 111.118 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.58 -22.68 29.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 73.34 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.4 mm -100.44 -19.56 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 73.42 111.145 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.35 18.88 50.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 52.42 112.48 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.99 -75.53 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 63.24 111.099 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.8 pt -60.16 -28.02 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 73.21 111.118 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.52 73.96 0.46 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.598 0.713 . . . . 72.53 111.093 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -39.69 6.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 74.11 112.311 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -129.6 -1.17 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 72.13 110.868 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.858 179.846 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.352 . . . . 71.13 110.906 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -99.27 100.8 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 74.2 110.893 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -124.86 -74.71 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 74.54 110.93 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -27.98 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 53.25 110.835 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 tp -55.18 -29.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.146 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -114.37 12.29 17.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 73.44 110.916 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -114.16 -38.66 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 74.22 110.858 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -90.84 -14.41 31.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.877 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.37 -40.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.42 111.126 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.33 45.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 64.33 111.118 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.24 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.848 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -14.76 27.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 64.32 110.912 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -5.15 5.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.735 -0.745 . . . . 64.03 112.508 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.8 p -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 73.1 111.119 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 pp -82.16 0.6 40.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.897 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.44 -20.8 18.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 53.35 112.516 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.09 -12.83 15.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 72.22 111.084 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.27 -41.47 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 70.11 111.109 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.4 -18.89 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 73.23 110.877 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.3 mm -105.55 -20.51 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 74.51 111.138 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.81 20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 74.35 112.496 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.3 -49.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 73.5 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -67.64 -31.51 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 74.34 111.106 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.75 73.9 0.88 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.642 0.734 . . . . 73.42 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -46.12 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.21 112.335 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -178.76 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.895 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 73.21 110.909 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 mttp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.881 0.372 . . . . 72.13 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.47 109.85 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.51 110.894 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.7 tp -168.67 123.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 73.33 110.929 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m 71.71 2.99 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.4 110.873 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.92 1.33 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 75.12 111.185 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.61 -32.11 4.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 75.52 110.947 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -96.14 -3.74 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 62.34 110.873 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -100.11 -19.38 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 74.02 110.91 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -121.39 -41.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.109 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.69 42.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 73.42 111.106 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tt -172.94 -35.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 73.14 110.916 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -86.21 -14.2 44.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.44 110.901 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -127.91 -3.37 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.445 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.7 t -87.64 -37.87 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 74.14 111.13 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.3 pp -81.32 -0.03 39.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.896 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.4 -20.02 20.82 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 75.22 112.494 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.05 -1.09 13.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 72.25 111.101 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.78 -40.69 9.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.16 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -23.5 16.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 73.41 110.941 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.5 mt -116.97 -21.51 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.119 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.25 19.24 48.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 62.14 112.512 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.07 -68.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 75.03 111.081 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -62.06 -26.96 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.428 . . . . 75.04 111.107 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 56.3 73.79 0.78 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.715 . . . . 71.21 111.106 179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -19.98 35.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.25 . . . . 75.5 112.307 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.73 22.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 74.2 110.862 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.5 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 74.52 110.917 179.861 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.6 mttm . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.856 0.36 . . . . 74.23 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -129.56 106.27 8.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 71.23 110.902 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' O ' ' CB ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -129.54 104.28 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 74.14 110.93 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER 79.32 -44.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.2 110.852 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 tp -52.98 -29.25 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.12 111.1 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -32.31 58.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.9 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.2 -21.5 29.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.34 110.88 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -91.07 -5.41 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.893 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.7 t -121.67 -51.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 73.51 111.165 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.82 46.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 73.14 111.063 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.24 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 75.13 110.95 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -93.2 -11.75 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.909 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.29 -0.71 5.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.508 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 8.3 p -88.08 -23.32 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 72.12 111.164 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.91 -0.31 38.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 73.42 110.889 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.08 -20.41 20.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 73.13 112.52 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.64 -0.42 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 71.35 111.13 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.67 -40.74 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 70.11 111.099 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -20.71 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 70.23 110.927 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp -116.72 -23.17 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 72.43 111.172 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.87 19.08 47.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.743 . . . . 63.54 112.511 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.02 -64.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 55.53 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.68 -26.53 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.33 111.129 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.43 73.98 0.54 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 72.22 111.087 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.8 -45.62 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.732 2.288 . . . . 72.31 112.323 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.42 22.9 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.43 110.908 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.2 mtpt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 74.52 110.883 179.901 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.849 0.357 . . . . 71.24 110.907 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -142.74 143.66 32.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 74.04 110.891 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -62.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 64.22 110.946 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -49.78 -51.69 37.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.87 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -54.14 -44.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 70.34 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.89 -1.26 42.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 75.14 110.862 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.45 -33.13 10.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 72.23 110.862 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.63 -12.56 45.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.872 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.28 -47.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.086 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.91 45.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.22 111.127 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.98 -32.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 64.23 110.91 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.51 -10.84 39.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.847 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.01 0.4 5.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 74.33 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.65 -20.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 73.25 111.162 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.79 -1.97 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.928 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.54 -19.63 20.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 74.55 112.501 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.58 -1.46 14.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.813 0.34 . . . . 65.11 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.15 -39.72 9.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 70.44 111.151 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.36 -23.89 15.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 74.43 110.923 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -117.31 -21.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.155 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.19 19.09 48.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 75.23 112.463 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.96 -70.32 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.728 0.299 . . . . 71.55 111.113 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.91 -30.8 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 72.14 111.154 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.32 73.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 74.23 111.09 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -29.96 23.19 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 73.54 112.339 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.7 22.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.914 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 73.53 110.874 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.887 0.375 . . . . 74.31 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 73.31 110.906 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.31 -74.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 74.3 110.93 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -53.37 -33.67 54.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.836 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -56.95 -23.83 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.21 111.175 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -112.57 -23.13 10.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.923 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.28 -27.28 47.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 70.53 110.927 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -83.55 -44.44 14.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 75.14 110.896 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.9 t -50.94 -27.35 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 74.2 111.092 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.0 31.94 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 74.45 111.072 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.72 -34.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.3 110.899 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -16.94 56.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 75.24 110.925 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.24 2.24 4.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.81 -0.71 . . . . 71.33 112.503 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.92 -25.15 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 71.34 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 24.7 mt -81.87 0.46 39.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 75.33 110.91 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.93 -19.43 22.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 74.23 112.46 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.55 1.07 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.304 . . . . 74.32 111.083 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.8 -42.53 8.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 74.21 111.081 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.92 -22.2 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 73.31 110.941 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.5 mm -116.75 -20.02 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.121 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.29 18.84 50.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.75 . . . . 72.21 112.461 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.35 -62.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 74.3 111.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.42 -24.99 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 74.23 111.144 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.03 73.9 0.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.568 0.699 . . . . 64.21 111.067 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -26.46 27.6 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.68 2.253 . . . . 74.43 112.351 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.74 23.04 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.45 110.896 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.949 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.5 mttt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 75.33 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.08 170.91 13.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.55 110.883 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -179.23 -74.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 74.22 110.916 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -54.04 -33.9 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.825 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.38 -27.15 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.177 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -112.64 8.32 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 64.21 110.946 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.87 -38.6 4.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 65.13 110.875 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -87.12 -13.92 42.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 72.02 110.882 -179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.6 t -113.62 -43.96 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 75.24 111.156 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.28 45.42 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 75.54 111.068 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.91 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 74.44 110.94 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -11.45 39.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 73.04 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.25 -0.41 5.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 71.22 112.473 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.43 -19.83 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 74.11 111.114 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.55 -1.89 34.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.893 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.67 -19.47 20.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 73.45 112.517 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.43 -1.43 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 73.43 111.128 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.7 -39.04 10.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 64.42 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.42 -21.35 17.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 74.42 110.918 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.28 -23.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 64.22 111.139 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.85 19.11 47.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 75.34 112.514 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.07 -51.81 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 72.3 111.106 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.16 -26.9 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.54 111.164 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.75 66.68 4.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 65.54 111.107 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 58.2 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.26 . . . . 73.22 112.387 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt 175.49 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.22 110.882 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.878 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.899 0.381 . . . . 73.31 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -122.91 143.07 50.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 75.35 110.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -174.92 -65.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 73.14 110.901 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -53.82 -33.3 55.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 74.34 110.841 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 tp -61.85 -27.81 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 74.32 111.119 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 33.2 m-85 -114.06 12.79 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.892 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.53 -40.39 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 71.12 110.871 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.28 -12.8 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.833 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.8 t -113.98 -43.95 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.2 111.119 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -92.69 44.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 62.53 111.085 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.64 -31.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.906 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -11.54 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.897 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -111.09 -18.16 8.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 63.53 112.494 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.6 t -87.4 -66.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 63.3 111.118 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt 45.98 30.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.921 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 50.71 29.24 18.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.498 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.61 -74.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 63.13 111.094 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.21 -52.25 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.078 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.26 -28.45 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.942 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 68.7 mt -88.0 -20.34 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 72.3 111.121 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.83 17.84 53.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 71.21 112.462 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.6 -74.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 75.13 111.142 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.39 -27.36 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 72.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.12 73.49 0.78 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.71 . . . . 72.32 111.114 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -31.27 20.57 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 65.24 112.37 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.73 23.05 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 71.44 110.866 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.25 110.883 179.846 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.873 0.368 . . . . 75.01 110.943 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp 63.48 169.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.886 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 tt 73.76 -66.27 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 75.51 110.923 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m -56.16 -21.48 23.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.857 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.22 -27.29 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 70.51 111.143 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -120.01 10.06 11.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.912 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -32.14 6.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 70.42 110.891 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 74.4 110.91 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 31.1 t -112.73 -36.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.3 111.128 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.94 45.48 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.076 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -32.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.66 -15.31 42.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 62.04 110.902 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.78 2.82 4.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 62.04 112.477 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.77 -24.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 74.4 111.101 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.67 0.22 39.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.899 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.5 -20.11 21.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 74.12 112.465 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.38 -0.5 13.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 75.42 111.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.02 -40.96 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 63.43 111.091 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -23.33 16.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 64.22 110.937 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.4 mt -117.08 -19.56 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.52 111.141 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 25.71 17.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 74.1 112.489 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.45 -58.43 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 73.44 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 pt -55.2 -29.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 75.33 111.095 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.86 74.87 0.41 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 74.41 111.088 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.77 -34.11 15.2 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 74.53 112.345 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -179.79 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 75.42 110.957 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.4 ptmt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 61.13 110.891 179.853 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.846 0.355 . . . . 73.23 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 110.89 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.32 110.892 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.6 123.35 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 61.21 110.913 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.17 2.54 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 73.34 110.855 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.17 0.53 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.32 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -116.91 -24.36 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.3 110.91 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -26.17 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 74.41 110.851 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.49 -14.22 38.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.863 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.7 -49.53 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 72.15 111.074 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.82 46.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.077 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.34 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 71.34 110.935 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -11.08 33.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 74.11 110.899 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.66 0.87 5.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 61.14 112.523 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -91.08 -23.65 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 73.21 111.143 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.4 mt -82.04 0.89 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.958 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.77 -19.45 21.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.753 -0.737 . . . . 71.54 112.527 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.85 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.743 0.306 . . . . 74.02 111.097 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -44.5 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.13 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -81.05 -20.23 42.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.914 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.55 -27.42 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.43 111.126 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.72 18.06 49.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 72.22 112.473 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 -61.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 75.4 111.083 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.94 -28.22 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.33 111.127 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.34 77.11 0.37 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.694 . . . . 74.33 111.097 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.19 17.08 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.672 2.248 . . . . 72.31 112.357 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.66 -33.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.902 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.846 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.844 0.354 . . . . 74.31 110.869 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -115.38 101.8 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.902 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.76 -75.12 0.48 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 72.44 110.873 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -55.23 -31.53 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.816 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 tp -53.33 -29.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.41 111.117 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.46 -10.87 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 74.32 110.941 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -27.41 22.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 70.3 110.91 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -41.98 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 75.21 110.856 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 86.5 t -55.51 -22.52 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.132 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -8.36 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 tp -134.91 -32.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 74.02 110.927 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -88.74 -18.11 28.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.15 110.87 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.83 -17.98 4.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 64.41 112.48 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.93 -24.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 63.32 111.128 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.4 -1.23 39.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.931 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.95 -20.05 17.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 54.32 112.485 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.78 -12.28 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 52.23 111.073 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.69 -42.82 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.069 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -84.9 -22.32 29.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 63.5 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.6 mm -101.2 -19.43 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 73.15 111.134 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.29 18.65 51.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 51.01 112.494 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.54 -67.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.307 . . . . 54.13 111.116 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.92 -28.34 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 74.34 111.138 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 58.17 71.09 1.09 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.559 0.695 . . . . 74.13 111.118 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -19.42 35.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.663 2.242 . . . . 74.35 112.304 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.77 23.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.894 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.853 179.902 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.847 0.356 . . . . 75.43 110.909 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -145.72 111.96 5.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 73.41 110.932 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.6 123.24 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 75.35 110.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.43 0.2 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 75.12 110.886 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.67 -1.55 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 75.21 111.115 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -108.49 -25.97 10.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 74.44 110.893 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -92.14 -21.98 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 74.12 110.937 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -88.24 -13.37 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 74.32 110.85 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.9 -52.74 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.139 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -88.92 48.13 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.22 111.07 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.66 -32.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.92 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -10.75 40.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.92 0.31 5.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 74.25 112.461 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -89.44 -19.83 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 71.23 111.097 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -100.71 0.65 39.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.885 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.64 -17.35 26.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 75.33 112.467 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.86 -9.84 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 75.34 111.085 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 -44.31 8.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.108 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.3 pp -79.77 -23.6 42.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 73.34 110.918 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.3 tt -59.29 -23.35 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.117 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.84 76.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 65.53 112.516 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.09 -75.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 64.13 111.082 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pt -63.87 -25.36 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 73.34 111.143 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.14 73.31 0.95 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.727 . . . . 63.33 111.118 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -19.19 36.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 74.45 112.307 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 22.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.33 110.914 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.7 mmmt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 74.52 110.887 179.893 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 74.54 110.895 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -152.24 109.6 3.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 72.52 110.907 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -167.0 128.54 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.9 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 74.99 -4.7 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 61.1 110.867 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.78 4.26 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.31 111.12 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -116.41 -27.14 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.11 110.911 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.16 -24.42 18.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 74.42 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -90.97 -6.62 53.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.54 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.33 -50.37 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.12 111.11 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.1 45.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.43 111.08 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -173.56 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.14 110.896 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.64 -11.09 56.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.869 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.93 6.0 3.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 74.01 112.501 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.42 -25.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 71.34 111.117 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -81.97 0.54 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 75.01 110.916 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.25 -21.08 17.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 72.03 112.472 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.88 -14.12 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 73.53 111.102 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.19 -43.22 13.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 73.52 111.104 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 -22.87 31.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.917 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.4 mm -102.09 -17.2 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 73.32 111.125 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.16 -19.8 40.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.718 -0.754 . . . . 73.41 112.501 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.33 48.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 73.53 111.086 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm 51.72 46.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 70.42 111.145 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.55 73.9 0.89 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.597 0.713 . . . . 60.21 111.077 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.4 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.716 2.278 . . . . 74.12 112.301 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -156.95 23.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 70.43 110.935 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 74.43 110.886 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.837 0.351 . . . . 41.32 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 tp -63.39 -27.14 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 53.24 111.133 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -112.64 7.95 18.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 75.14 110.889 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.42 -38.24 4.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.44 110.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -87.24 -14.28 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.875 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.0 t -113.06 -43.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 52.04 111.085 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.01 46.25 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.095 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.85 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 71.42 110.897 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -12.38 43.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.881 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.31 4.42 4.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 42.55 112.468 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.49 -25.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 51.14 111.107 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.7 mt -81.59 0.1 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.31 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.1 -21.15 16.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 71.33 112.476 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.74 -12.35 15.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 74.51 111.094 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.29 -43.6 12.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 62.32 111.131 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.43 -22.71 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.54 110.933 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 61.21 111.159 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.843 0.354 . . . . 52.11 110.827 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.52 -27.73 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 73.2 111.124 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -113.22 9.75 18.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.918 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.43 -40.18 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 64.25 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -86.84 -14.95 40.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.864 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 8' ' ' ARG . 65.8 t -113.4 -42.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 53.22 111.122 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.48 44.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 71.34 111.077 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.24 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.953 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.32 -12.27 43.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.883 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.27 4.41 4.13 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.44 112.462 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -101.64 -25.07 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.879 0.371 . . . . 72.33 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.66 0.16 39.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.911 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -54.18 -21.16 17.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.759 . . . . 70.33 112.472 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.96 -11.69 15.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 53.24 111.106 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.02 -42.79 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 62.33 111.071 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.42 -22.35 28.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 75.21 110.935 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 16' ' ' GLY . 23.9 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.05 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.886 0.374 . . . . 70.52 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 6' ' ' TYR . 11.0 tp -62.88 -27.32 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 72.21 111.145 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 43.2 m-85 -113.56 10.87 18.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 74.02 110.949 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -38.94 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 75.3 110.89 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -14.02 42.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.866 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -113.14 -43.58 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 63.24 111.14 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.04 45.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.21 111.1 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.86 -32.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 65.33 110.975 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -11.9 42.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 61.02 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.79 4.86 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 54.01 112.468 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.65 -24.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 72.43 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 0.25 39.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 73.03 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.51 -20.17 22.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 71.42 112.46 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.15 -0.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 72.4 111.098 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.77 -40.9 9.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.151 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -23.42 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 60.2 110.919 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.2 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.21 111.159 179.826 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.898 0.38 . . . . 72.35 110.906 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -63.36 -27.26 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 74.32 111.146 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -112.66 8.67 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 71.51 110.902 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.27 -38.84 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 61.22 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.466 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.18 -13.54 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.3 110.863 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 8' ' ' ARG . 26.1 t -113.84 -44.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 75.25 111.126 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -91.02 45.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 70.14 111.077 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.427 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.61 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.893 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -11.5 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.913 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.55 0.64 5.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 52.41 112.506 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 15' ' ' LEU . 8.2 p -90.84 -24.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 64.22 111.113 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD23 HG13 ' A' ' 14' ' ' VAL . 9.6 mt -81.19 -0.1 38.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.914 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -53.91 -21.37 16.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 61.34 112.478 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.14 -12.08 15.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.52 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.7 -42.97 12.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 64.5 111.074 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.09 -22.4 28.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 73.21 110.937 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 16' ' ' GLY . 24.0 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.24 111.158 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.831 0.348 . . . . 74.55 110.846 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.605 HD12 HH21 ' A' ' 8' ' ' ARG . 1.0 OUTLIER -61.3 -26.56 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 74.04 111.154 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.547 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -116.24 8.37 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.918 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.36 -37.79 4.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 72.14 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.605 HH21 HD12 ' A' ' 5' ' ' ILE . 2.9 ptt85 -89.23 -14.68 35.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 62.45 110.855 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 ' HG2' ' A' ' 8' ' ' ARG . 45.8 t -113.04 -41.97 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 55.12 111.119 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -95.68 45.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.73 -32.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 64.12 110.961 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -13.55 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 52.01 110.863 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -3.4 5.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 75.03 112.447 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.82 -38.64 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 65.44 111.158 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 19' ' ' LEU . 4.3 pp -82.15 0.74 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 70.33 110.914 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.37 -20.92 18.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 64.04 112.49 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.5 -15.41 15.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 34.25 111.114 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.52 -42.43 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 75.22 111.108 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -83.78 -23.02 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 54.22 110.952 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.074 179.863 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.839 0.352 . . . . 62.24 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.87 -26.84 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 75.24 111.204 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -116.53 8.24 13.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.45 110.914 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.84 -37.22 4.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 64.03 110.904 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -89.96 -14.98 32.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.9 t -112.79 -41.42 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.23 111.141 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.82 46.14 1.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.23 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.94 -32.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.921 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -13.39 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 71.3 110.885 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.69 3.79 4.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 74.0 112.474 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -101.21 -25.97 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 53.31 111.099 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.4 -1.07 39.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.904 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.45 -21.02 18.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 75.14 112.525 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.83 5.18 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 60.1 111.11 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.99 -41.29 7.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 70.33 111.099 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.45 -19.51 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.938 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 20' ' ' ILE . 17.6 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.14 111.123 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.844 0.354 . . . . 72.11 110.84 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.63 -26.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.146 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -115.97 7.08 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.11 110.931 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -37.38 5.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 9' ' ' VAL . 2.2 ppt_? -89.04 -15.96 32.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.12 110.841 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 8' ' ' ARG . 30.6 t -113.33 -41.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 52.04 111.146 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -97.65 39.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 42.05 111.119 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -172.05 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 65.12 110.906 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.37 -12.84 56.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.877 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.81 4.91 4.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.71 -0.757 . . . . 64.44 112.467 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.8 -25.34 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 41.15 111.123 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.88 0.4 39.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.905 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.31 -21.08 18.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 73.33 112.506 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.18 -12.52 15.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.2 111.126 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 -41.59 12.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 32.2 111.068 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.48 -18.78 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.926 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 62.02 111.128 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 72.44 110.867 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -62.18 -26.96 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 73.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m-85 -114.94 10.94 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.936 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -116.62 -39.01 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 45.51 110.897 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.99 -13.82 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 74.22 110.882 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.1 t -112.75 -43.28 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 63.31 111.108 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -95.22 46.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.109 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.45 110.906 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -12.65 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 60.45 110.87 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.04 4.1 4.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 70.42 112.478 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.1 t -101.05 -25.03 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 74.01 111.124 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -81.65 0.19 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 35.12 110.939 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.12 -21.18 17.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 43.13 112.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.76 -12.26 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 63.34 111.082 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.47 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.13 111.118 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.58 -22.68 29.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 70.51 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 63.02 111.145 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.8 0.333 . . . . 53.25 110.835 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 tp -55.18 -29.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.146 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -114.37 12.29 17.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.916 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -114.16 -38.66 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 73.35 110.858 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -90.84 -14.41 31.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.877 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.37 -40.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 71.52 111.126 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.33 45.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 64.33 111.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.24 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.848 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -14.76 27.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 64.32 110.912 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -5.15 5.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.735 -0.745 . . . . 64.03 112.508 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 11' ' ' LEU . 9.8 p -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 73.1 111.119 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.2 pp -82.16 0.6 40.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.897 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.44 -20.8 18.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 53.02 112.516 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.09 -12.83 15.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 62.21 111.084 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.27 -41.47 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 70.11 111.109 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.4 -18.89 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 73.23 110.877 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.3 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 71.12 111.138 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.905 0.383 . . . . 72.05 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.92 1.33 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 75.12 111.185 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.61 -32.11 4.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 75.52 110.947 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.692 ' CG ' HD13 ' A' ' 11' ' ' LEU . 1.2 mt-10 -96.14 -3.74 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 62.34 110.873 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -100.11 -19.38 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.21 110.91 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -121.39 -41.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.109 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.69 42.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 71.33 111.106 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CG ' ' A' ' 7' ' ' GLU . 3.5 tt -172.94 -35.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 45.13 110.916 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -86.21 -14.2 44.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.901 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -127.91 -3.37 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.445 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.7 t -87.64 -37.87 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 73.22 111.13 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.3 pp -81.32 -0.03 39.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.896 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.4 -20.02 20.82 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 75.22 112.494 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.05 -1.09 13.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 72.25 111.101 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.78 -40.69 9.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.16 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -23.5 16.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.21 110.941 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.119 179.86 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 72.2 110.852 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.9 tp -52.98 -29.25 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.12 111.1 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -32.31 58.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.9 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.2 -21.5 29.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.34 110.88 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -91.07 -5.41 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.893 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 5' ' ' ILE . 94.7 t -121.67 -51.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.51 111.165 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.82 46.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 73.14 111.063 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.24 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 65.35 110.95 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -93.2 -11.75 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.909 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.29 -0.71 5.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.508 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 15' ' ' LEU . 8.3 p -88.08 -23.32 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 72.12 111.164 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 14' ' ' VAL . 8.0 mt -80.91 -0.31 38.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 54.25 110.889 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.08 -20.41 20.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 73.13 112.52 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.64 -0.42 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 64.03 111.13 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.67 -40.74 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 70.11 111.099 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -20.71 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 53.12 110.927 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.53 111.172 179.793 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 72.11 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -54.14 -44.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 70.34 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.68 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -80.89 -1.26 42.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.862 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.45 -33.13 10.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 72.23 110.862 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.63 -12.56 45.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.872 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.28 -47.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.086 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -90.91 45.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.21 111.127 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.98 -32.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.01 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.51 -10.84 39.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 70.24 110.847 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.01 0.4 5.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 71.54 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.65 -20.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 73.25 111.162 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.79 -1.97 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.928 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.54 -19.63 20.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 64.3 112.501 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.58 -1.46 14.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.813 0.34 . . . . 65.11 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.15 -39.72 9.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 70.44 111.151 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.36 -23.89 15.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.15 110.923 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 64.32 111.155 179.787 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.848 0.356 . . . . 75.44 110.836 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 9' ' ' VAL . 10.5 tp -56.95 -23.83 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.21 111.175 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -112.57 -23.13 10.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.923 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.28 -27.28 47.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 70.53 110.927 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -83.55 -44.44 14.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 70.42 110.896 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 5' ' ' ILE . 93.9 t -50.94 -27.35 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.43 111.092 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.0 31.94 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 62.4 111.072 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.72 -34.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.3 110.899 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -16.94 56.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 72.53 110.925 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.24 2.24 4.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.81 -0.71 . . . . 65.23 112.503 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.92 -25.15 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 71.34 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HB3' HD23 ' A' ' 19' ' ' LEU . 24.7 mt -81.87 0.46 39.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 73.42 110.91 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.93 -19.43 22.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 71.54 112.46 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.55 1.07 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.304 . . . . 74.32 111.083 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.8 -42.53 8.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 71.12 111.081 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -97.92 -22.2 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 70.54 110.941 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 19' ' ' LEU . 26.5 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.121 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.823 0.344 . . . . 64.34 110.825 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.38 -27.15 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.177 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -112.64 8.32 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 63.12 110.946 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.87 -38.6 4.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 64.41 110.875 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 9' ' ' VAL . 9.6 ptt180 -87.12 -13.92 42.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 64.35 110.882 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 8' ' ' ARG . 47.6 t -113.62 -43.96 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.156 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -92.28 45.42 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 75.54 111.068 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 72.21 110.94 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -11.45 39.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 61.24 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.25 -0.41 5.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 42.13 112.473 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.43 -19.83 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 55.14 111.114 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.55 -1.89 34.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.893 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.67 -19.47 20.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 73.45 112.517 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.43 -1.43 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 52.44 111.128 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.7 -39.04 10.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 64.42 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.42 -21.35 17.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.918 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 61.12 111.139 179.805 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.9 0.381 . . . . 71.22 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 6' ' ' TYR . 8.3 tp -61.85 -27.81 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 74.32 111.119 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CG ' HG23 ' A' ' 5' ' ' ILE . 33.2 m-85 -114.06 12.79 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.892 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.53 -40.39 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 65.44 110.871 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -87.28 -12.8 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 54.21 110.833 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 8' ' ' ARG . 21.8 t -113.98 -43.95 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.2 111.119 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -92.69 44.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 62.53 111.085 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.64 -31.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.906 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -11.54 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.897 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -111.09 -18.16 8.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 63.53 112.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 16' ' ' GLY . 73.6 t -87.4 -66.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 52.53 111.118 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt 45.98 30.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.921 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.738 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 50.71 29.24 18.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.498 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.61 -74.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 54.21 111.094 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -51.21 -52.25 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.26 -28.45 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.942 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 16' ' ' GLY . 68.7 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 71.31 111.121 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.876 0.37 . . . . 74.51 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.22 -27.29 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 70.51 111.143 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -120.01 10.06 11.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.912 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -32.14 6.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 52.21 110.891 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.91 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' HG2' ' A' ' 8' ' ' ARG . 31.1 t -112.73 -36.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.3 111.128 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -101.94 45.48 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -32.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.66 -15.31 42.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 62.04 110.902 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.78 2.82 4.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 62.04 112.477 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.77 -24.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 53.52 111.101 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.67 0.22 39.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.899 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.5 -20.11 21.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 74.12 112.465 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.38 -0.5 13.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 61.2 111.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.02 -40.96 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 63.43 111.091 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -23.33 16.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 64.22 110.937 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.52 111.141 179.855 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.84 0.352 . . . . 73.34 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.17 0.53 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.32 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -116.91 -24.36 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.01 110.91 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -26.17 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.851 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.49 -14.22 38.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.863 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.7 -49.53 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 60.35 111.074 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -89.82 46.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.077 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.34 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 71.34 110.935 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -11.08 33.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 61.14 110.899 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.66 0.87 5.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 32.43 112.523 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 15' ' ' LEU . 7.7 p -91.08 -23.65 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 73.1 111.143 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.733 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.4 mt -82.04 0.89 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.958 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.77 -19.45 21.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.753 -0.737 . . . . 71.54 112.527 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.85 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.743 0.306 . . . . 74.02 111.097 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -44.5 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.13 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.7 mm? -81.05 -20.23 42.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.914 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 53.54 111.126 179.836 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.836 0.35 . . . . 74.23 110.816 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.5 tp -53.33 -29.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.32 111.117 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.46 -10.87 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 71.03 110.941 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -27.41 22.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 63.54 110.91 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -41.98 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 61.54 110.856 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 5' ' ' ILE . 86.5 t -55.51 -22.52 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.132 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -8.36 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 tp -134.91 -32.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.927 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -88.74 -18.11 28.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.15 110.87 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.83 -17.98 4.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 53.01 112.48 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.93 -24.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 63.32 111.128 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.4 -1.23 39.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.931 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.95 -20.05 17.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 51.11 112.485 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.78 -12.28 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 45.04 111.073 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.69 -42.82 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.069 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -84.9 -22.32 29.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 42.12 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.134 179.855 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 74.1 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.67 -1.55 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 70.55 111.115 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -108.49 -25.97 10.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 61.23 110.893 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -92.14 -21.98 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 74.12 110.937 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -88.24 -13.37 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.85 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.9 -52.74 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.139 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -88.92 48.13 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.21 111.07 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.66 -32.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.92 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -10.75 40.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.92 0.31 5.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 72.13 112.461 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -89.44 -19.83 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 55.24 111.097 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -100.71 0.65 39.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 55.14 110.885 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.64 -17.35 26.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 51.55 112.467 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.86 -9.84 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.23 111.085 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 -44.31 8.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.108 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 15' ' ' LEU . 1.3 pp -79.77 -23.6 42.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.41 110.918 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.117 179.871 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.881 0.372 . . . . 13.51 110.867 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.78 4.26 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.31 111.12 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -116.41 -27.14 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.11 110.911 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.16 -24.42 18.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 74.42 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -90.97 -6.62 53.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.21 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.33 -50.37 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.12 111.11 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.1 45.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.14 111.08 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -173.56 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.14 110.896 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.64 -11.09 56.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.21 110.869 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.93 6.0 3.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 74.01 112.501 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.42 -25.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 71.12 111.117 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -81.97 0.54 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.916 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.25 -21.08 17.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 43.53 112.472 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.88 -14.12 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 73.53 111.102 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.19 -43.22 13.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 52.34 111.104 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 -22.87 31.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.917 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 23.42 111.125 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.802 0.334 . . . . 64.21 110.933 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -172.05 152.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.52 110.91 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.19 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 44.22 110.908 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.506 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -54.09 -33.8 58.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 41.32 110.846 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 tp -63.39 -27.14 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 53.24 111.133 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -112.64 7.95 18.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 75.14 110.889 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.42 -38.24 4.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.44 110.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -87.24 -14.28 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.4 110.875 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.0 t -113.06 -43.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 52.04 111.085 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.01 46.25 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 64.41 111.095 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.85 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 71.42 110.897 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -12.38 43.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.13 110.881 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.31 4.42 4.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 42.55 112.468 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.49 -25.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 51.14 111.107 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.7 mt -81.59 0.1 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.31 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.1 -21.15 16.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 71.33 112.476 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.74 -12.35 15.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 74.51 111.094 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.29 -43.6 12.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 62.32 111.131 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.43 -22.71 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.54 110.933 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mm -100.35 -19.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 61.21 111.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.24 18.44 51.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.757 . . . . 41.42 112.463 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.96 -74.09 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.716 0.293 . . . . 72.22 111.109 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -57.48 -28.38 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 74.52 111.118 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.87 73.64 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 65.31 111.064 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.87 15.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.627 2.218 . . . . 70.4 112.322 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 23.01 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 63.22 110.906 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.34 110.883 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.847 0.356 . . . . 73.55 110.87 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -168.21 144.11 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 75.42 110.848 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.18 -63.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.947 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -53.56 -33.4 54.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 52.11 110.827 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.52 -27.73 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 73.2 111.124 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -113.22 9.75 18.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 75.31 110.918 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.43 -40.18 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 64.25 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -86.84 -14.95 40.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.13 110.864 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 8' ' ' ARG . 65.8 t -113.4 -42.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 53.22 111.122 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.48 44.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 71.34 111.077 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.24 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.953 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.32 -12.27 43.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.14 110.883 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.27 4.41 4.13 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.44 112.462 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -101.64 -25.07 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.879 0.371 . . . . 72.33 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.66 0.16 39.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.911 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -54.18 -21.16 17.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.759 . . . . 70.33 112.472 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.96 -11.69 15.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 53.24 111.106 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.02 -42.79 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 62.33 111.071 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.42 -22.35 28.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 75.21 110.935 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 16' ' ' GLY . 23.9 mt -101.1 -19.98 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.05 111.154 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.14 18.43 51.53 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 70.44 112.487 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.22 -66.21 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 53.34 111.066 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.3 -37.82 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 75.03 111.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.64 70.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.579 0.704 . . . . 74.54 111.122 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -27.59 26.43 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.268 . . . . 64.12 112.363 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.74 23.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 62.14 110.902 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.1 110.904 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.823 0.344 . . . . 63.21 110.931 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 154.7 47.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 54.3 110.934 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.17 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 75.4 110.893 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.497 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -53.89 -34.11 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 70.52 110.882 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 6' ' ' TYR . 11.0 tp -62.88 -27.32 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 72.21 111.145 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 43.2 m-85 -113.56 10.87 18.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 74.02 110.949 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -38.94 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 75.3 110.89 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -14.02 42.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.44 110.866 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -113.14 -43.58 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 63.24 111.14 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.04 45.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.21 111.1 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.86 -32.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 65.33 110.975 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -11.9 42.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 61.02 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.79 4.86 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 54.01 112.468 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.65 -24.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 72.43 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 0.25 39.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 73.03 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.51 -20.17 22.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 71.42 112.46 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.15 -0.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 72.4 111.098 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.77 -40.9 9.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 70.35 111.151 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -23.42 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 60.2 110.919 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.747 HG23 ' HG3' ' A' ' 25' ' ' PRO . 28.2 mt -116.99 -21.42 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.21 111.159 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.38 19.59 46.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 62.03 112.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.93 -67.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 53.21 111.117 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 pt -52.53 -29.11 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.22 111.156 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.82 74.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.571 0.701 . . . . 72.11 111.081 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.747 ' HG3' HG23 ' A' ' 20' ' ' ILE . 54.1 Cg_endo -69.76 -43.29 2.74 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.673 2.249 . . . . 75.13 112.39 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.6 24.36 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 61.54 110.89 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.11 110.925 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.845 0.355 . . . . 64.5 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -173.22 159.51 3.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 74.25 110.949 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.25 -74.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.14 110.89 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -53.99 -33.92 58.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 72.35 110.906 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -63.36 -27.26 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 74.32 111.146 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -112.66 8.67 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 71.51 110.902 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.27 -38.84 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 61.22 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.466 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.18 -13.54 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.3 110.863 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 8' ' ' ARG . 26.1 t -113.84 -44.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 75.25 111.126 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -91.02 45.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 70.14 111.077 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.427 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.61 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.893 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -11.5 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.52 110.913 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.55 0.64 5.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 52.41 112.506 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 15' ' ' LEU . 8.2 p -90.84 -24.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 64.22 111.113 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD23 HG13 ' A' ' 14' ' ' VAL . 9.6 mt -81.19 -0.1 38.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 74.14 110.914 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -53.91 -21.37 16.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 61.34 112.478 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.14 -12.08 15.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.52 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.7 -42.97 12.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 64.5 111.074 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.09 -22.4 28.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 73.21 110.937 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.757 HG23 ' HG3' ' A' ' 25' ' ' PRO . 24.0 mt -101.16 -18.33 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.24 111.158 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.03 25.78 18.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 74.04 112.459 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.5 -55.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 44.23 111.088 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -52.01 -29.55 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 64.2 111.125 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.74 74.31 0.47 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.71 . . . . 73.33 111.094 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HG3' HG23 ' A' ' 20' ' ' ILE . 54.2 Cg_endo -69.76 -16.67 37.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 73.24 112.335 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.75 -33.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.03 110.896 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' NZ ' HG22 ' A' ' 20' ' ' ILE . 6.6 ptpt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 61.4 110.927 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.821 0.343 . . . . 75.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -146.55 107.65 4.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 73.15 110.948 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -75.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 55.02 110.931 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -28.84 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 74.55 110.846 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.605 HD12 HH21 ' A' ' 8' ' ' ARG . 1.0 OUTLIER -61.3 -26.56 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 74.04 111.154 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.547 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -116.24 8.37 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.13 110.918 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.36 -37.79 4.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 72.14 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.605 HH21 HD12 ' A' ' 5' ' ' ILE . 2.9 ptt85 -89.23 -14.68 35.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 62.45 110.855 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 ' HG2' ' A' ' 8' ' ' ARG . 45.8 t -113.04 -41.97 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 55.12 111.119 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -95.68 45.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.52 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.73 -32.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 64.12 110.961 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -13.55 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 52.01 110.863 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -3.4 5.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 75.03 112.447 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.82 -38.64 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 65.44 111.158 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 19' ' ' LEU . 4.3 pp -82.15 0.74 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 70.33 110.914 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.37 -20.92 18.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 64.04 112.49 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.5 -15.41 15.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 34.25 111.114 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' A' ' 27' ' ' LYS . . . -85.52 -42.43 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 75.22 111.108 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -83.78 -23.02 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 54.22 110.952 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -104.09 -15.03 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.074 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.35 -21.97 35.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 74.42 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.75 47.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 75.42 111.123 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm 51.64 47.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 63.24 111.147 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HB2' HD23 ' A' ' 19' ' ' LEU . . . 51.63 74.06 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.596 0.712 . . . . 40.44 111.113 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -29.0 24.46 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 55.13 112.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 23.09 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.1 110.895 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 8.5 mmtt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.43 110.926 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.9 mttm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 65.24 110.922 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 125.17 42.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 75.14 110.931 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.37 -67.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.42 110.901 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -62.79 -28.51 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 62.24 110.847 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.87 -26.84 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 75.24 111.204 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -116.53 8.24 13.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.45 110.914 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.84 -37.22 4.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 64.03 110.904 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -89.96 -14.98 32.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 75.34 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.9 t -112.79 -41.42 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.23 111.141 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.82 46.14 1.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.23 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.94 -32.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.21 110.921 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -13.39 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 71.3 110.885 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.69 3.79 4.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 74.0 112.474 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -101.21 -25.97 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 53.31 111.099 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.4 -1.07 39.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.21 110.904 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.45 -21.02 18.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 75.14 112.525 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.83 5.18 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 60.1 111.11 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.99 -41.29 7.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 70.33 111.099 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.45 -19.51 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 71.24 110.938 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.421 HG22 ' O ' ' A' ' 20' ' ' ILE . 17.6 mt -119.65 -6.55 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.14 111.123 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.15 -27.46 23.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 52.0 112.469 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.33 40.62 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 72.24 111.09 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm 51.7 44.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.4 111.141 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.46 74.23 0.83 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 73.0 111.073 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -48.49 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.272 . . . . 72.34 112.336 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.95 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.14 110.896 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 75.13 110.916 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.5 mttm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.898 0.38 . . . . 64.43 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.65 99.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 61.11 110.873 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.76 -75.31 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 64.11 110.929 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -55.3 -28.47 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 72.11 110.84 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.63 -26.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.23 111.146 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -115.97 7.08 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.11 110.931 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -37.38 5.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.23 110.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 9' ' ' VAL . 2.2 ppt_? -89.04 -15.96 32.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.12 110.841 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 8' ' ' ARG . 30.6 t -113.33 -41.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 52.04 111.146 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -97.65 39.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 42.05 111.119 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -172.05 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 65.12 110.906 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.37 -12.84 56.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.33 110.877 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.81 4.91 4.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.71 -0.757 . . . . 64.44 112.467 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.8 -25.34 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 41.15 111.123 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.88 0.4 39.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.905 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.31 -21.08 18.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 73.33 112.506 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.18 -12.52 15.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.2 111.126 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 -41.59 12.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 32.2 111.068 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.48 -18.78 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.926 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' A' ' 27' ' ' LYS . 26.0 mm -105.59 -20.64 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 62.02 111.128 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.71 20.13 43.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.762 . . . . 75.34 112.45 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.83 -49.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 54.41 111.116 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.6 -31.45 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 71.13 111.129 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 52.69 71.62 1.4 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.55 0.691 . . . . 73.13 111.059 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 20' ' ' ILE . 54.0 Cg_endo -69.77 -16.89 37.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.247 . . . . 63.13 112.336 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.83 -33.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 62.25 110.896 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG2' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 71.43 110.909 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.866 0.365 . . . . 63.25 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -111.85 133.98 53.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 62.33 110.904 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.22 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 72.03 110.903 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.97 -32.49 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 72.44 110.867 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -62.18 -26.96 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 73.14 111.143 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m-85 -114.94 10.94 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.936 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -116.62 -39.01 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 45.51 110.897 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.99 -13.82 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 74.22 110.882 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.1 t -112.75 -43.28 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 63.31 111.108 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -95.22 46.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.33 111.109 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.45 110.906 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -12.65 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 60.45 110.87 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.04 4.1 4.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 70.42 112.478 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.1 t -101.05 -25.03 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 74.01 111.124 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -81.65 0.19 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 35.12 110.939 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.12 -21.18 17.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 43.13 112.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.76 -12.26 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 63.34 111.082 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.47 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.13 111.118 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.58 -22.68 29.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 70.51 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.474 HG23 ' CG ' ' A' ' 25' ' ' PRO . 28.4 mm -100.44 -19.56 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 63.02 111.145 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.35 18.88 50.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 52.42 112.48 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.99 -75.53 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 62.4 111.099 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.8 pt -60.16 -28.02 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 73.21 111.118 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.52 73.96 0.46 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.598 0.713 . . . . 72.53 111.093 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' CG ' HG23 ' A' ' 20' ' ' ILE . 53.6 Cg_endo -69.75 -39.69 6.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 74.11 112.311 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -129.6 -1.17 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 63.4 110.868 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.33 110.858 179.846 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.352 . . . . 71.13 110.906 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.604 ' O ' HD13 ' A' ' 3' ' ' LEU . 7.1 mtmp? -99.27 100.8 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 70.53 110.893 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 2' ' ' LYS . 1.9 mm? -124.86 -74.71 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 64.32 110.93 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -27.98 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 53.25 110.835 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 tp -55.18 -29.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.03 111.146 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -114.37 12.29 17.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 73.4 110.916 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -114.16 -38.66 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 73.35 110.858 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -90.84 -14.41 31.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.23 110.877 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.37 -40.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 71.52 111.126 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.33 45.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 64.33 111.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.24 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.44 110.848 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -14.76 27.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 64.32 110.912 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -5.15 5.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.735 -0.745 . . . . 64.03 112.508 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 11' ' ' LEU . 9.8 p -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 73.1 111.119 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.2 pp -82.16 0.6 40.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.34 110.897 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.44 -20.8 18.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 53.02 112.516 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.09 -12.83 15.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 62.21 111.084 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.27 -41.47 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 70.11 111.109 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.4 -18.89 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 73.23 110.877 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 25' ' ' PRO . 26.3 mm -105.55 -20.51 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 71.12 111.138 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.81 20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 74.35 112.496 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.3 -49.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 73.5 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -67.64 -31.51 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 72.21 111.106 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.75 73.9 0.88 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.642 0.734 . . . . 73.42 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 20' ' ' ILE . 53.7 Cg_endo -69.78 -46.12 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.21 112.335 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -178.76 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.33 110.895 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 53.42 110.909 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 mttp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.881 0.372 . . . . 62.32 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.47 109.85 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.51 110.894 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.7 tp -168.67 123.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 51.51 110.929 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m 71.71 2.99 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 72.05 110.873 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.92 1.33 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 75.12 111.185 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.61 -32.11 4.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 75.52 110.947 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' CG ' HD13 ' A' ' 11' ' ' LEU . 1.2 mt-10 -96.14 -3.74 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 62.34 110.873 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -100.11 -19.38 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.21 110.91 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -121.39 -41.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 74.35 111.109 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.69 42.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 71.33 111.106 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CG ' ' A' ' 7' ' ' GLU . 3.5 tt -172.94 -35.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 45.13 110.916 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -86.21 -14.2 44.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.14 110.901 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -127.91 -3.37 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 75.43 112.445 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.7 t -87.64 -37.87 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 73.22 111.13 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.462 ' C ' HD12 ' A' ' 15' ' ' LEU . 4.3 pp -81.32 -0.03 39.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.14 110.896 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.4 -20.02 20.82 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 75.22 112.494 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.05 -1.09 13.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 72.25 111.101 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.78 -40.69 9.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 74.4 111.16 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -23.5 16.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.21 110.941 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.5 mt -116.97 -21.51 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.24 111.119 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.25 19.24 48.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 62.14 112.512 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.07 -68.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 75.03 111.081 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -62.06 -26.96 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.428 . . . . 75.04 111.107 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 27' ' ' LYS . . . 56.3 73.79 0.78 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.715 . . . . 71.21 111.106 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -19.98 35.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.25 . . . . 75.5 112.307 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.73 22.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.22 110.862 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 10.5 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 61.04 110.917 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.6 mttm . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.856 0.36 . . . . 63.21 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -129.56 106.27 8.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 51.44 110.902 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' O ' ' CB ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -129.54 104.28 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 73.23 110.93 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER 79.32 -44.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.2 110.852 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.9 tp -52.98 -29.25 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.12 111.1 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -32.31 58.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 74.42 110.9 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.2 -21.5 29.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.34 110.88 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -91.07 -5.41 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.23 110.893 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 5' ' ' ILE . 94.7 t -121.67 -51.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.51 111.165 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.82 46.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 73.14 111.063 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.24 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 65.35 110.95 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -93.2 -11.75 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.54 110.909 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.29 -0.71 5.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.778 -0.725 . . . . 72.43 112.508 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 15' ' ' LEU . 8.3 p -88.08 -23.32 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 72.12 111.164 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 14' ' ' VAL . 8.0 mt -80.91 -0.31 38.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 54.25 110.889 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.08 -20.41 20.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 73.13 112.52 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.64 -0.42 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 64.03 111.13 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.67 -40.74 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 70.11 111.099 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -20.71 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 53.12 110.927 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.758 HG22 ' HD2' ' A' ' 27' ' ' LYS . 2.0 mp -116.72 -23.17 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.53 111.172 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.87 19.08 47.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.743 . . . . 62.34 112.511 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.02 -64.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 44.33 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.68 -26.53 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.33 111.129 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.43 73.98 0.54 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 72.22 111.087 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.717 ' HG3' HG23 ' A' ' 20' ' ' ILE . 53.6 Cg_endo -69.8 -45.62 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.732 2.288 . . . . 72.31 112.323 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.42 22.9 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.43 110.908 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.758 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.2 mtpt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 73.4 110.883 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.849 0.357 . . . . 55.1 110.907 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -142.74 143.66 32.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 64.34 110.891 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -62.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 54.04 110.946 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -49.78 -51.69 37.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.11 110.87 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -54.14 -44.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 70.34 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.68 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -80.89 -1.26 42.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 74.23 110.862 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.45 -33.13 10.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 72.23 110.862 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.63 -12.56 45.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.33 110.872 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.28 -47.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.13 111.086 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -90.91 45.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.21 111.127 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.98 -32.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.01 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.51 -10.84 39.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 70.24 110.847 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.01 0.4 5.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 71.54 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.65 -20.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 73.25 111.162 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.79 -1.97 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.23 110.928 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.54 -19.63 20.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 64.3 112.501 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.58 -1.46 14.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.813 0.34 . . . . 65.11 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.15 -39.72 9.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 70.44 111.151 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.36 -23.89 15.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.15 110.923 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -117.31 -21.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 64.32 111.155 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.19 19.09 48.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 52.14 112.463 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.96 -70.32 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.728 0.299 . . . . 71.55 111.113 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.91 -30.8 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 54.53 111.154 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.32 73.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 55.35 111.09 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -29.96 23.19 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 73.54 112.339 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.7 22.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 72.52 110.914 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 73.53 110.874 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.887 0.375 . . . . 55.21 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 60.25 110.906 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.31 -74.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 72.04 110.93 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -53.37 -33.67 54.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.836 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 9' ' ' VAL . 10.5 tp -56.95 -23.83 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.21 111.175 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -112.57 -23.13 10.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.923 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.28 -27.28 47.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 70.53 110.927 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -83.55 -44.44 14.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 70.42 110.896 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 5' ' ' ILE . 93.9 t -50.94 -27.35 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.43 111.092 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.0 31.94 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 62.4 111.072 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.72 -34.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.3 110.899 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -16.94 56.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 72.53 110.925 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.24 2.24 4.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.81 -0.71 . . . . 65.23 112.503 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.92 -25.15 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 71.34 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HB3' HD23 ' A' ' 19' ' ' LEU . 24.7 mt -81.87 0.46 39.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 73.42 110.91 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.93 -19.43 22.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 71.54 112.46 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.55 1.07 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.304 . . . . 74.32 111.083 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.8 -42.53 8.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 71.12 111.081 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -97.92 -22.2 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 70.54 110.941 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 19' ' ' LEU . 26.5 mm -116.75 -20.02 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.42 111.121 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.29 18.84 50.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.75 . . . . 72.21 112.461 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.35 -62.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 74.3 111.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.42 -24.99 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 62.53 111.144 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.03 73.9 0.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.568 0.699 . . . . 20.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -26.46 27.6 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.68 2.253 . . . . 74.43 112.351 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.74 23.04 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.45 110.896 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.03 110.949 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.5 mttt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 75.33 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.08 170.91 13.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.55 110.883 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.23 -74.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.41 110.916 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.462 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -54.04 -33.9 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 64.34 110.825 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.38 -27.15 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.23 111.177 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -112.64 8.32 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 63.12 110.946 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.87 -38.6 4.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 64.41 110.875 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 9' ' ' VAL . 9.6 ptt180 -87.12 -13.92 42.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 64.35 110.882 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 8' ' ' ARG . 47.6 t -113.62 -43.96 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 74.41 111.156 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -92.28 45.42 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 75.54 111.068 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 72.21 110.94 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -11.45 39.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 61.24 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.25 -0.41 5.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 42.13 112.473 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.43 -19.83 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 55.14 111.114 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.55 -1.89 34.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.42 110.893 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.67 -19.47 20.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 73.45 112.517 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.43 -1.43 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 52.44 111.128 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.7 -39.04 10.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 64.42 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.42 -21.35 17.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.918 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.28 -23.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 61.12 111.139 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.85 19.11 47.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 64.42 112.514 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.07 -51.81 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 72.3 111.106 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.16 -26.9 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.14 111.164 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.75 66.68 4.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 50.01 111.107 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 58.2 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.26 . . . . 64.22 112.387 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt 175.49 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.22 110.882 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.878 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.899 0.381 . . . . 73.31 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -122.91 143.07 50.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 65.02 110.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -174.92 -65.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 53.24 110.901 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -53.82 -33.3 55.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 71.22 110.841 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 6' ' ' TYR . 8.3 tp -61.85 -27.81 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 74.32 111.119 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CG ' HG23 ' A' ' 5' ' ' ILE . 33.2 m-85 -114.06 12.79 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.14 110.892 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.53 -40.39 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 65.44 110.871 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -87.28 -12.8 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 54.21 110.833 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 8' ' ' ARG . 21.8 t -113.98 -43.95 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.2 111.119 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -92.69 44.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 62.53 111.085 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.64 -31.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 74.54 110.906 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -11.54 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.52 110.897 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -111.09 -18.16 8.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 63.53 112.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 16' ' ' GLY . 73.6 t -87.4 -66.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 52.53 111.118 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt 45.98 30.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.32 110.921 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.738 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 50.71 29.24 18.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 73.42 112.498 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.61 -74.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 54.21 111.094 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -51.21 -52.25 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.26 -28.45 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.942 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 16' ' ' GLY . 68.7 mt -88.0 -20.34 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 71.31 111.121 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.83 17.84 53.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 40.44 112.462 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.6 -74.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 60.11 111.142 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.39 -27.36 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 72.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.12 73.49 0.78 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.71 . . . . 63.44 111.114 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -31.27 20.57 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 64.3 112.37 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.73 23.05 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 71.44 110.866 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.1 110.883 179.846 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.873 0.368 . . . . 74.15 110.943 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp 63.48 169.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.44 110.886 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 tt 73.76 -66.27 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 75.12 110.923 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m -56.16 -21.48 23.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.51 110.857 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.22 -27.29 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 70.51 111.143 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -120.01 10.06 11.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.912 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -32.14 6.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 52.21 110.891 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 74.3 110.91 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' HG2' ' A' ' 8' ' ' ARG . 31.1 t -112.73 -36.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.3 111.128 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -101.94 45.48 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.24 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -32.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.66 -15.31 42.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 62.04 110.902 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.78 2.82 4.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 62.04 112.477 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.77 -24.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 53.52 111.101 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.67 0.22 39.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.45 110.899 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.5 -20.11 21.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 74.12 112.465 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.38 -0.5 13.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 61.2 111.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.02 -40.96 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 63.43 111.091 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -23.33 16.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 64.22 110.937 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.808 HG22 ' HD3' ' A' ' 27' ' ' LYS . 26.4 mt -117.08 -19.56 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.52 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 25.71 17.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 74.1 112.489 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.45 -58.43 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 73.44 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 pt -55.2 -29.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 75.33 111.095 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.86 74.87 0.41 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 64.53 111.088 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.71 ' HG3' HG23 ' A' ' 20' ' ' ILE . 53.9 Cg_endo -69.77 -34.11 15.2 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 74.53 112.345 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -179.79 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 71.32 110.957 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.808 ' HD3' HG22 ' A' ' 20' ' ' ILE . 11.4 ptmt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 45.23 110.891 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.846 0.355 . . . . 62.02 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 110.89 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.32 110.892 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.6 123.35 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 61.21 110.913 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.17 2.54 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 73.34 110.855 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.17 0.53 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.32 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -116.91 -24.36 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.01 110.91 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -26.17 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 74.12 110.851 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.49 -14.22 38.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.1 110.863 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.7 -49.53 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 60.35 111.074 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -89.82 46.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.42 111.077 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.34 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 71.34 110.935 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -11.08 33.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 61.14 110.899 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.66 0.87 5.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 32.43 112.523 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 15' ' ' LEU . 7.7 p -91.08 -23.65 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 73.1 111.143 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.733 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.4 mt -82.04 0.89 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.13 110.958 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.77 -19.45 21.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.753 -0.737 . . . . 71.54 112.527 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.85 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.743 0.306 . . . . 74.02 111.097 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -44.5 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 71.51 111.13 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.7 mm? -81.05 -20.23 42.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.11 110.914 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.55 -27.42 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 53.54 111.126 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.72 18.06 49.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 72.22 112.473 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 -61.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 75.4 111.083 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.94 -28.22 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.33 111.127 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.34 77.11 0.37 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.694 . . . . 74.33 111.097 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.19 17.08 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.672 2.248 . . . . 54.43 112.357 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.66 -33.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 74.55 110.902 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.846 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.844 0.354 . . . . 74.31 110.869 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -115.38 101.8 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 71.43 110.902 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.76 -75.12 0.48 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 72.44 110.873 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -55.23 -31.53 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.23 110.816 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.5 tp -53.33 -29.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.32 111.117 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.46 -10.87 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 71.03 110.941 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -27.41 22.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 63.54 110.91 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -41.98 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 61.54 110.856 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 5' ' ' ILE . 86.5 t -55.51 -22.52 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.43 111.132 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -8.36 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 63.34 111.138 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 tp -134.91 -32.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 71.21 110.927 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -88.74 -18.11 28.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.15 110.87 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.83 -17.98 4.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 53.01 112.48 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.93 -24.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 63.32 111.128 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.4 -1.23 39.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 75.31 110.931 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.95 -20.05 17.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 51.11 112.485 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.78 -12.28 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 45.04 111.073 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.69 -42.82 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 72.43 111.069 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -84.9 -22.32 29.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 42.12 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.6 mm -101.2 -19.43 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.134 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.29 18.65 51.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 34.32 112.494 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.54 -67.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.307 . . . . 54.13 111.116 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.92 -28.34 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 42.52 111.138 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 27' ' ' LYS . . . 58.17 71.09 1.09 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.559 0.695 . . . . 74.13 111.118 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -19.42 35.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.663 2.242 . . . . 64.55 112.304 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.77 23.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.894 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 16.7 mmtm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.53 110.853 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.847 0.356 . . . . 73.22 110.909 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -145.72 111.96 5.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 64.52 110.932 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.6 123.24 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 74.44 110.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.43 0.2 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.1 110.886 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.67 -1.55 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 70.55 111.115 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -108.49 -25.97 10.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 61.23 110.893 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -92.14 -21.98 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 74.12 110.937 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -88.24 -13.37 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.85 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.9 -52.74 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.32 111.139 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -88.92 48.13 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.21 111.07 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.66 -32.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.13 110.92 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -10.75 40.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.23 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.92 0.31 5.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 72.13 112.461 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -89.44 -19.83 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 55.24 111.097 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -100.71 0.65 39.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 55.14 110.885 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.64 -17.35 26.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 51.55 112.467 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.86 -9.84 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.23 111.085 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 -44.31 8.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 74.14 111.108 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 15' ' ' LEU . 1.3 pp -79.77 -23.6 42.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.41 110.918 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.3 tt -59.29 -23.35 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.44 111.117 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.84 76.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 33.13 112.516 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.09 -75.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 63.24 111.082 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pt -63.87 -25.36 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 61.04 111.143 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 27' ' ' LYS . . . 53.14 73.31 0.95 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.727 . . . . 51.54 111.118 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -19.19 36.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 71.23 112.307 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 22.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.33 110.914 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 8.7 mmmt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 72.14 110.887 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 74.54 110.895 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -152.24 109.6 3.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 50.12 110.907 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -167.0 128.54 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 75.34 110.9 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 74.99 -4.7 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 13.51 110.867 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.78 4.26 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.31 111.12 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -116.41 -27.14 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.11 110.911 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.16 -24.42 18.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 74.42 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -90.97 -6.62 53.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.21 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.33 -50.37 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.12 111.11 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.1 45.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.14 111.08 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -173.56 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.14 110.896 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.64 -11.09 56.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.21 110.869 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.93 6.0 3.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 74.01 112.501 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.42 -25.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 71.12 111.117 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -81.97 0.54 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.32 110.916 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.25 -21.08 17.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 43.53 112.472 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.88 -14.12 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 73.53 111.102 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.502 ' HB1' ' HG3' ' A' ' 27' ' ' LYS . . . -86.19 -43.22 13.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 52.34 111.104 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 -22.87 31.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.51 110.917 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.4 mm -102.09 -17.2 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 23.42 111.125 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.16 -19.8 40.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.718 -0.754 . . . . 73.41 112.501 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.33 48.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 73.53 111.086 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm 51.72 46.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 62.12 111.145 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.55 73.9 0.89 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.597 0.713 . . . . 54.04 111.077 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.4 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.716 2.278 . . . . 45.33 112.301 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -156.95 23.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 61.31 110.935 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 71.44 110.886 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.837 0.351 . . . . 41.32 110.846 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 tp -63.39 -27.14 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 53.240000000000002 111.133 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -112.64 7.95 18.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 110.889 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.42 -38.24 4.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.439999999999998 110.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -87.24 -14.28 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 110.875 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.0 t -113.06 -43.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 52.039999999999999 111.085 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.01 46.25 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 64.409999999999997 111.095 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.85 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 71.420000000000002 110.897 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -12.38 43.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.129999999999995 110.881 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.31 4.42 4.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 42.549999999999997 112.468 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.49 -25.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 51.140000000000001 111.107 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.7 mt -81.59 0.1 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.310000000000002 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.1 -21.15 16.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 71.329999999999998 112.476 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.74 -12.35 15.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 74.510000000000005 111.094 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.29 -43.6 12.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 62.32 111.131 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.43 -22.71 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.933 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mm . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.159 179.828 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.843 0.354 . . . . 52.109999999999999 110.827 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.52 -27.73 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 73.200000000000003 111.124 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -113.22 9.75 18.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.918 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.43 -40.18 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 64.25 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -86.84 -14.95 40.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.129999999999995 110.864 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 8' ' ' ARG . 65.8 t -113.4 -42.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 53.219999999999999 111.122 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.48 44.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 71.340000000000003 111.077 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.24 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.953 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.32 -12.27 43.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.883 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.27 4.41 4.13 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.439999999999998 112.462 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -101.64 -25.07 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.879 0.371 . . . . 72.329999999999998 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.66 0.16 39.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.911 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -54.18 -21.16 17.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.759 . . . . 70.329999999999998 112.472 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.96 -11.69 15.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 53.240000000000002 111.106 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.02 -42.79 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 62.329999999999998 111.071 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.42 -22.35 28.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.935 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 16' ' ' GLY . 23.9 mt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.049999999999997 111.154 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.886 0.374 . . . . 70.519999999999996 110.882 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 6' ' ' TYR . 11.0 tp -62.88 -27.32 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 72.209999999999994 111.145 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 43.2 m-85 -113.56 10.87 18.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 110.949 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -38.94 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 75.299999999999997 110.89 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -14.02 42.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.866 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -113.14 -43.58 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 111.14 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.04 45.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.209999999999994 111.1 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.86 -32.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 65.329999999999998 110.975 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -11.9 42.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 61.020000000000003 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.79 4.86 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 54.009999999999998 112.468 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.65 -24.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 72.430000000000007 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 0.25 39.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 73.030000000000001 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.51 -20.17 22.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 71.420000000000002 112.46 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.15 -0.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 72.400000000000006 111.098 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.77 -40.9 9.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 70.349999999999994 111.151 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -23.42 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 60.200000000000003 110.919 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.2 mt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.210000000000001 111.159 179.826 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.898 0.38 . . . . 72.349999999999994 110.906 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -63.36 -27.26 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 111.146 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -112.66 8.67 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 71.510000000000005 110.902 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.27 -38.84 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 61.219999999999999 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.466 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.18 -13.54 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.299999999999997 110.863 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 8' ' ' ARG . 26.1 t -113.84 -44.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 75.25 111.126 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -91.02 45.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 70.140000000000001 111.077 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.427 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.61 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.893 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -11.5 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.519999999999996 110.913 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.55 0.64 5.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 52.409999999999997 112.506 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 15' ' ' LEU . 8.2 p -90.84 -24.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 64.219999999999999 111.113 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.463 HD23 HG13 ' A' ' 14' ' ' VAL . 9.6 mt -81.19 -0.1 38.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.914 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -53.91 -21.37 16.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 61.340000000000003 112.478 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.14 -12.08 15.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.519999999999996 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.7 -42.97 12.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 64.5 111.074 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.09 -22.4 28.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 73.209999999999994 110.937 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.463 HD12 ' O ' ' A' ' 16' ' ' GLY . 24.0 mt . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 111.158 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.831 0.348 . . . . 74.549999999999997 110.846 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.605 HD12 HH21 ' A' ' 8' ' ' ARG . 1.0 OUTLIER -61.3 -26.56 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 74.040000000000006 111.154 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.547 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -116.24 8.37 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.918 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.36 -37.79 4.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 72.140000000000001 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.605 HH21 HD12 ' A' ' 5' ' ' ILE . 2.9 ptt85 -89.23 -14.68 35.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 62.450000000000003 110.855 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 ' HG2' ' A' ' 8' ' ' ARG . 45.8 t -113.04 -41.97 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 55.119999999999997 111.119 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -95.68 45.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.519999999999996 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.73 -32.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 64.120000000000005 110.961 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -13.55 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 52.009999999999998 110.863 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -3.4 5.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 75.030000000000001 112.447 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.82 -38.64 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 65.439999999999998 111.158 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 19' ' ' LEU . 4.3 pp -82.15 0.74 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 70.329999999999998 110.914 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.37 -20.92 18.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 64.040000000000006 112.49 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.5 -15.41 15.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 34.25 111.114 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -85.52 -42.43 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 111.108 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.495 ' CD1' HD13 ' A' ' 15' ' ' LEU . 0.2 OUTLIER -83.78 -23.02 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 54.219999999999999 110.952 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 111.074 179.863 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.839 0.352 . . . . 62.240000000000002 110.847 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.87 -26.84 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 75.239999999999995 111.204 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -116.53 8.24 13.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.450000000000003 110.914 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.84 -37.22 4.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 64.030000000000001 110.904 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -89.96 -14.98 32.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.9 t -112.79 -41.42 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 111.141 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.82 46.14 1.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.230000000000004 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.94 -32.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.209999999999994 110.921 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -13.39 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 71.299999999999997 110.885 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.69 3.79 4.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 74.0 112.474 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -101.21 -25.97 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 53.310000000000002 111.099 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.4 -1.07 39.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 110.904 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.45 -21.02 18.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 75.140000000000001 112.525 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.83 5.18 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 60.100000000000001 111.11 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.99 -41.29 7.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 70.329999999999998 111.099 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.45 -19.51 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 110.938 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' HG22 ' A' ' 20' ' ' ILE . 17.6 mt . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.140000000000001 111.123 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.844 0.354 . . . . 72.109999999999999 110.84 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.63 -26.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 111.146 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -115.97 7.08 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.931 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -37.38 5.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.230000000000004 110.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 9' ' ' VAL . 2.2 ppt_? -89.04 -15.96 32.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.119999999999997 110.841 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 8' ' ' ARG . 30.6 t -113.33 -41.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 52.039999999999999 111.146 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -97.65 39.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 42.049999999999997 111.119 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -172.05 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 110.906 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.37 -12.84 56.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.877 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.81 4.91 4.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.71 -0.757 . . . . 64.439999999999998 112.467 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.8 -25.34 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 41.149999999999999 111.123 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.88 0.4 39.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.905 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.31 -21.08 18.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 73.329999999999998 112.506 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.18 -12.52 15.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.200000000000003 111.126 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 -41.59 12.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 32.200000000000003 111.068 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.48 -18.78 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 110.926 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 62.020000000000003 111.128 179.841 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.899 0.38 . . . . 72.439999999999998 110.867 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -62.18 -26.96 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 73.140000000000001 111.143 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m-85 -114.94 10.94 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.936 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -116.62 -39.01 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 45.509999999999998 110.897 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.99 -13.82 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 74.219999999999999 110.882 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.1 t -112.75 -43.28 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 63.310000000000002 111.108 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -95.22 46.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.109 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.450000000000003 110.906 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -12.65 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 110.87 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.04 4.1 4.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 70.420000000000002 112.478 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.1 t -101.05 -25.03 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 74.010000000000005 111.124 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -81.65 0.19 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 35.119999999999997 110.939 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.12 -21.18 17.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 43.130000000000003 112.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.76 -12.26 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 63.340000000000003 111.082 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.47 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 111.118 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.58 -22.68 29.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 70.510000000000005 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.4 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 63.020000000000003 111.145 179.842 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.8 0.333 . . . . 53.25 110.835 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 tp -55.18 -29.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.030000000000001 111.146 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -114.37 12.29 17.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.916 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -114.16 -38.66 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 73.349999999999994 110.858 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -90.84 -14.41 31.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.877 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.37 -40.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 111.126 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.33 45.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 64.329999999999998 111.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.24 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.848 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -14.76 27.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 64.319999999999993 110.912 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -5.15 5.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.735 -0.745 . . . . 64.030000000000001 112.508 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 11' ' ' LEU . 9.8 p -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 73.099999999999994 111.119 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 15' ' ' LEU . 4.2 pp -82.16 0.6 40.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.897 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.44 -20.8 18.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 53.020000000000003 112.516 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.09 -12.83 15.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 62.210000000000001 111.084 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.27 -41.47 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 70.109999999999999 111.109 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.4 -18.89 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.877 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.3 mm . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 71.120000000000005 111.138 179.84 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.905 0.383 . . . . 72.049999999999997 110.873 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.92 1.33 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 75.120000000000005 111.185 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.61 -32.11 4.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 75.519999999999996 110.947 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.692 ' CG ' HD13 ' A' ' 11' ' ' LEU . 1.2 mt-10 -96.14 -3.74 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 62.340000000000003 110.873 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -100.11 -19.38 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.209999999999994 110.91 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -121.39 -41.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 74.349999999999994 111.109 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.69 42.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 71.329999999999998 111.106 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CG ' ' A' ' 7' ' ' GLU . 3.5 tt -172.94 -35.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 45.130000000000003 110.916 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -86.21 -14.2 44.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.901 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -127.91 -3.37 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 75.430000000000007 112.445 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.7 t -87.64 -37.87 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 73.219999999999999 111.13 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 15' ' ' LEU . 4.3 pp -81.32 -0.03 39.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.896 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.4 -20.02 20.82 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 75.219999999999999 112.494 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.05 -1.09 13.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 72.25 111.101 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.78 -40.69 9.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 74.400000000000006 111.16 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -23.5 16.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.209999999999994 110.941 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.5 mt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 111.119 179.86 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.869 0.366 . . . . 72.200000000000003 110.852 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.9 tp -52.98 -29.25 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 111.1 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -32.31 58.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 74.420000000000002 110.9 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.2 -21.5 29.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.340000000000003 110.88 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -91.07 -5.41 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.893 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 5' ' ' ILE . 94.7 t -121.67 -51.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.510000000000005 111.165 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.82 46.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 73.140000000000001 111.063 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.24 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 65.349999999999994 110.95 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -93.2 -11.75 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.540000000000006 110.909 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.29 -0.71 5.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.778 -0.725 . . . . 72.430000000000007 112.508 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 15' ' ' LEU . 8.3 p -88.08 -23.32 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 72.120000000000005 111.164 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 14' ' ' VAL . 8.0 mt -80.91 -0.31 38.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 54.25 110.889 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.08 -20.41 20.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 73.129999999999995 112.52 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.64 -0.42 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 64.030000000000001 111.13 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.67 -40.74 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 70.109999999999999 111.099 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -20.71 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 53.119999999999997 110.927 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.530000000000001 111.172 179.793 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.876 0.37 . . . . 72.109999999999999 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -54.14 -44.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 70.340000000000003 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.68 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -80.89 -1.26 42.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.862 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.45 -33.13 10.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.862 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.63 -12.56 45.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.872 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.28 -47.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.086 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -90.91 45.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.209999999999994 111.127 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.98 -32.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.009999999999998 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.51 -10.84 39.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 70.239999999999995 110.847 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.01 0.4 5.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 71.540000000000006 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.65 -20.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 73.25 111.162 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.79 -1.97 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.928 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.54 -19.63 20.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 64.299999999999997 112.501 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.58 -1.46 14.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.813 0.34 . . . . 65.109999999999999 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.15 -39.72 9.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 70.439999999999998 111.151 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.36 -23.89 15.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.150000000000006 110.923 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 64.319999999999993 111.155 179.787 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.848 0.356 . . . . 75.439999999999998 110.836 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 9' ' ' VAL . 10.5 tp -56.95 -23.83 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.209999999999994 111.175 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -112.57 -23.13 10.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 110.923 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.28 -27.28 47.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 70.530000000000001 110.927 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -83.55 -44.44 14.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 70.420000000000002 110.896 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 5' ' ' ILE . 93.9 t -50.94 -27.35 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.43 111.092 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.0 31.94 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 62.399999999999999 111.072 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.72 -34.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.299999999999997 110.899 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -16.94 56.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 72.530000000000001 110.925 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.24 2.24 4.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.81 -0.71 . . . . 65.230000000000004 112.503 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.92 -25.15 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 71.340000000000003 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HB3' HD23 ' A' ' 19' ' ' LEU . 24.7 mt -81.87 0.46 39.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 73.420000000000002 110.91 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.93 -19.43 22.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 71.540000000000006 112.46 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.55 1.07 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.304 . . . . 74.319999999999993 111.083 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.8 -42.53 8.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 71.120000000000005 111.081 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -97.92 -22.2 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 70.540000000000006 110.941 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 19' ' ' LEU . 26.5 mm . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.121 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.823 0.344 . . . . 64.340000000000003 110.825 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.38 -27.15 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 111.177 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -112.64 8.32 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 63.119999999999997 110.946 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.87 -38.6 4.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 64.409999999999997 110.875 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 9' ' ' VAL . 9.6 ptt180 -87.12 -13.92 42.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 64.349999999999994 110.882 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 8' ' ' ARG . 47.6 t -113.62 -43.96 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.156 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -92.28 45.42 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 75.540000000000006 111.068 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 72.209999999999994 110.94 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -11.45 39.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 61.240000000000002 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.25 -0.41 5.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 42.130000000000003 112.473 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.43 -19.83 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 55.140000000000001 111.114 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.55 -1.89 34.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.893 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.67 -19.47 20.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 73.450000000000003 112.517 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.43 -1.43 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 52.439999999999998 111.128 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.7 -39.04 10.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 64.420000000000002 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.42 -21.35 17.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.918 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 61.119999999999997 111.139 179.805 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.9 0.381 . . . . 71.219999999999999 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 6' ' ' TYR . 8.3 tp -61.85 -27.81 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 111.119 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CG ' HG23 ' A' ' 5' ' ' ILE . 33.2 m-85 -114.06 12.79 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.892 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.53 -40.39 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 65.439999999999998 110.871 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -87.28 -12.8 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 54.210000000000001 110.833 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 8' ' ' ARG . 21.8 t -113.98 -43.95 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.200000000000003 111.119 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -92.69 44.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 62.530000000000001 111.085 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.64 -31.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 110.906 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -11.54 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.519999999999996 110.897 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -111.09 -18.16 8.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 63.530000000000001 112.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 16' ' ' GLY . 73.6 t -87.4 -66.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 52.530000000000001 111.118 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt 45.98 30.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.921 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.738 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 50.71 29.24 18.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 73.420000000000002 112.498 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.61 -74.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 54.210000000000001 111.094 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -51.21 -52.25 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.26 -28.45 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 73.510000000000005 110.942 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 16' ' ' GLY . 68.7 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 71.310000000000002 111.121 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.876 0.37 . . . . 74.510000000000005 110.857 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.22 -27.29 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 70.510000000000005 111.143 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -120.01 10.06 11.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.912 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -32.14 6.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 52.210000000000001 110.891 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 74.299999999999997 110.91 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' HG2' ' A' ' 8' ' ' ARG . 31.1 t -112.73 -36.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.299999999999997 111.128 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -101.94 45.48 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -32.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.66 -15.31 42.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 62.039999999999999 110.902 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.78 2.82 4.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 62.039999999999999 112.477 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.77 -24.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 53.520000000000003 111.101 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.67 0.22 39.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.450000000000003 110.899 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.5 -20.11 21.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 74.120000000000005 112.465 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.38 -0.5 13.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 61.200000000000003 111.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.02 -40.96 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 63.43 111.091 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -23.33 16.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 64.219999999999999 110.937 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 26.4 mt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 111.141 179.855 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.84 0.352 . . . . 73.340000000000003 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.17 0.53 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.319999999999993 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -116.91 -24.36 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.010000000000005 110.91 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -26.17 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 74.120000000000005 110.851 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.49 -14.22 38.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.099999999999994 110.863 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.7 -49.53 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 60.350000000000001 111.074 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -89.82 46.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.077 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.34 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 71.340000000000003 110.935 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -11.08 33.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 61.140000000000001 110.899 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.66 0.87 5.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 32.43 112.523 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 15' ' ' LEU . 7.7 p -91.08 -23.65 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 73.099999999999994 111.143 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.733 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.4 mt -82.04 0.89 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.129999999999995 110.958 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.77 -19.45 21.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.753 -0.737 . . . . 71.540000000000006 112.527 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.85 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.743 0.306 . . . . 74.019999999999996 111.097 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -44.5 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 71.510000000000005 111.13 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.7 mm? -81.05 -20.23 42.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.109999999999999 110.914 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 53.539999999999999 111.126 179.836 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m . . . . . 0 C--O 1.232 0.159 0 CA-C-O 120.836 0.35 . . . . 74.230000000000004 110.816 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.5 tp -53.33 -29.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.319999999999993 111.117 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.46 -10.87 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 71.030000000000001 110.941 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -27.41 22.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 63.539999999999999 110.91 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -41.98 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 61.539999999999999 110.856 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 5' ' ' ILE . 86.5 t -55.51 -22.52 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.132 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -8.36 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 63.340000000000003 111.138 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 tp -134.91 -32.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 71.209999999999994 110.927 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -88.74 -18.11 28.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 110.87 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.83 -17.98 4.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 53.009999999999998 112.48 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.93 -24.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 63.32 111.128 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.4 -1.23 39.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.931 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.95 -20.05 17.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 51.109999999999999 112.485 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.78 -12.28 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 45.039999999999999 111.073 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.69 -42.82 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 72.430000000000007 111.069 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -84.9 -22.32 29.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 42.119999999999997 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.6 mm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.134 179.855 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.87 0.367 . . . . 74.099999999999994 110.886 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.67 -1.55 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 70.549999999999997 111.115 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -108.49 -25.97 10.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 61.229999999999997 110.893 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -92.14 -21.98 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 74.120000000000005 110.937 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -88.24 -13.37 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.85 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.9 -52.74 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 111.139 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -88.92 48.13 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 111.07 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.66 -32.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.92 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -10.75 40.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.230000000000004 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.92 0.31 5.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 72.129999999999995 112.461 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -89.44 -19.83 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 55.240000000000002 111.097 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -100.71 0.65 39.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 55.140000000000001 110.885 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.64 -17.35 26.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 51.549999999999997 112.467 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.86 -9.84 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.230000000000004 111.085 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 -44.31 8.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.108 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 15' ' ' LEU . 1.3 pp -79.77 -23.6 42.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.409999999999997 110.918 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 111.117 179.871 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.881 0.372 . . . . 13.51 110.867 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.78 4.26 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 111.12 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -116.41 -27.14 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.911 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.16 -24.42 18.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 74.420000000000002 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -90.97 -6.62 53.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.209999999999994 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.33 -50.37 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 111.11 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.1 45.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.140000000000001 111.08 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -173.56 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.140000000000001 110.896 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.64 -11.09 56.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.869 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.93 6.0 3.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 74.010000000000005 112.501 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.42 -25.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 71.120000000000005 111.117 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -81.97 0.54 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.916 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.25 -21.08 17.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 43.530000000000001 112.472 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.88 -14.12 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 73.530000000000001 111.102 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -86.19 -43.22 13.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 52.340000000000003 111.104 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 -22.87 31.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.917 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.4 mm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 23.420000000000002 111.125 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.802 0.334 . . . . 64.209999999999994 110.933 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 ptmt -172.05 152.69 2.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 74.519999999999996 110.91 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.506 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.19 -74.49 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 44.219999999999999 110.908 179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.506 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -54.09 -33.8 58.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 41.32 110.846 -179.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.9 tp -63.39 -27.14 42.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.139 -0.482 . . . . 53.240000000000002 111.133 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.532 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -112.64 7.95 18.92 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 110.889 -179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.42 -38.24 4.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.137 -0.483 . . . . 52.439999999999998 110.884 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.404 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.6 OUTLIER -87.24 -14.28 41.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.17 -0.468 . . . . 74.400000000000006 110.875 -179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.404 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.0 t -113.06 -43.92 4.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.451 . . . . 52.039999999999999 111.085 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.532 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.01 46.25 1.17 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 64.409999999999997 111.095 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.85 -32.67 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.255 -0.429 . . . . 71.420000000000002 110.897 -179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.46 -12.38 43.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.454 . . . . 74.129999999999995 110.881 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.31 4.42 4.12 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.741 -0.742 . . . . 42.549999999999997 112.468 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -101.49 -25.09 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.901 0.382 . . . . 51.140000000000001 111.107 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 28.7 mt -81.59 0.1 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.196 -0.456 . . . . 70.310000000000002 110.914 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.1 -21.15 16.99 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.7 -0.762 . . . . 71.329999999999998 112.476 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.74 -12.35 15.55 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.331 . . . . 74.510000000000005 111.094 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.29 -43.6 12.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 62.32 111.131 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mt -84.43 -22.71 30.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 72.540000000000006 110.933 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.6 mm -100.35 -19.53 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 61.210000000000001 111.159 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.24 18.44 51.72 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.709 -0.757 . . . . 41.420000000000002 112.463 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -126.96 -74.09 0.6 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.716 0.293 . . . . 72.219999999999999 111.109 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -57.48 -28.38 31.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.233 -0.439 . . . . 74.519999999999996 111.118 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.87 73.64 0.64 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.598 0.713 . . . . 65.310000000000002 111.064 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.8 -33.87 15.58 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.627 2.218 . . . . 70.400000000000006 112.322 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.71 23.01 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 63.219999999999999 110.906 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 mmtt . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 75.340000000000003 110.883 179.871 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.847 0.356 . . . . 73.549999999999997 110.87 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -168.21 144.11 3.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 75.420000000000002 110.848 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.18 -63.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 74.209999999999994 110.947 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -53.56 -33.4 54.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 52.109999999999999 110.827 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 tp -60.52 -27.73 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.479 . . . . 73.200000000000003 111.124 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.514 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -113.22 9.75 18.45 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.184 -0.462 . . . . 75.310000000000002 110.918 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -113.43 -40.18 3.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 64.25 110.904 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.553 ' HG3' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -86.84 -14.95 40.62 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 73.129999999999995 110.864 -179.952 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.553 HG23 ' HG3' ' A' ' 8' ' ' ARG . 65.8 t -113.4 -42.76 4.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.244 -0.434 . . . . 53.219999999999999 111.122 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.48 44.55 1.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.198 -0.456 . . . . 71.340000000000003 111.077 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.402 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.24 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 73.25 110.953 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -88.32 -12.27 43.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 74.140000000000001 110.883 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.27 4.41 4.13 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.757 -0.735 . . . . 55.439999999999998 112.462 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -101.64 -25.07 3.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.879 0.371 . . . . 72.329999999999998 111.145 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 26.5 mt -81.66 0.16 39.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.169 -0.469 . . . . 72.25 110.911 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -54.18 -21.16 17.59 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.705 -0.759 . . . . 70.329999999999998 112.472 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.96 -11.69 15.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.806 0.336 . . . . 53.240000000000002 111.106 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.02 -42.79 12.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 62.329999999999998 111.071 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 pp -85.42 -22.35 28.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 75.209999999999994 110.935 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.455 HD12 ' O ' ' A' ' 16' ' ' GLY . 23.9 mt -101.1 -19.98 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 75.049999999999997 111.154 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.14 18.43 51.53 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 70.439999999999998 112.487 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -141.22 -66.21 0.42 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 53.340000000000003 111.066 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 76.5 mt -57.3 -37.82 58.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.258 -0.428 . . . . 75.030000000000001 111.137 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 59.64 70.94 0.98 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.579 0.704 . . . . 74.540000000000006 111.122 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.73 -27.59 26.43 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.703 2.268 . . . . 64.120000000000005 112.363 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.74 23.0 0.33 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.203 -0.453 . . . . 62.140000000000001 110.902 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.459 . . . . 74.099999999999994 110.904 179.875 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 4.4 tttm . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.823 0.344 . . . . 63.210000000000001 110.931 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.05 154.7 47.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.202 -0.454 . . . . 54.299999999999997 110.934 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.497 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.17 -74.53 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 75.400000000000006 110.893 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.497 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.9 OUTLIER -53.89 -34.11 58.51 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 70.519999999999996 110.882 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.443 HG23 ' CD2' ' A' ' 6' ' ' TYR . 11.0 tp -62.88 -27.32 42.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.136 -0.484 . . . . 72.209999999999994 111.145 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 43.2 m-85 -113.56 10.87 18.18 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.471 . . . . 74.019999999999996 110.949 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -116.75 -38.94 3.36 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 75.299999999999997 110.89 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 -14.02 42.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 74.439999999999998 110.866 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 64.3 t -113.14 -43.58 4.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 63.240000000000002 111.14 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.04 45.99 1.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 72.209999999999994 111.1 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.86 -32.62 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 65.329999999999998 110.975 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -89.03 -11.9 42.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 61.020000000000003 110.89 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.79 4.86 4.0 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.765 -0.731 . . . . 54.009999999999998 112.468 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.3 t -102.65 -24.74 3.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.842 0.353 . . . . 72.430000000000007 111.126 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 46.5 mt -81.65 0.25 39.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.214 -0.448 . . . . 73.030000000000001 110.923 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.51 -20.17 22.3 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.724 -0.751 . . . . 71.420000000000002 112.46 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.15 -0.96 13.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.815 0.341 . . . . 72.400000000000006 111.098 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.77 -40.9 9.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.444 . . . . 70.349999999999994 111.151 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.08 -23.42 16.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 60.200000000000003 110.919 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.747 HG23 ' HG3' ' A' ' 25' ' ' PRO . 28.2 mt -116.99 -21.42 4.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.163 -0.471 . . . . 62.210000000000001 111.159 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.38 19.59 46.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.762 -0.732 . . . . 62.030000000000001 112.517 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -132.93 -67.81 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.776 0.322 . . . . 53.210000000000001 111.117 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 24.8 pt -52.53 -29.11 13.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.204 -0.453 . . . . 72.219999999999999 111.156 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.82 74.34 0.44 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.571 0.701 . . . . 72.109999999999999 111.081 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.747 ' HG3' HG23 ' A' ' 20' ' ' ILE . 54.1 Cg_endo -69.76 -43.29 2.74 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.673 2.249 . . . . 75.129999999999995 112.39 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -159.6 24.36 0.19 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.184 -0.462 . . . . 61.539999999999999 110.89 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.454 . . . . 73.109999999999999 110.925 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 22.4 mtpt . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.845 0.355 . . . . 64.5 110.897 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -173.22 159.51 3.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 74.25 110.949 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.468 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.25 -74.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 72.140000000000001 110.89 179.94 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.468 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.6 OUTLIER -53.99 -33.92 58.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.229 -0.441 . . . . 72.349999999999994 110.906 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.7 tp -63.36 -27.26 42.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.09 -0.505 . . . . 74.319999999999993 111.146 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.8 OUTLIER -112.66 8.67 19.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.157 -0.474 . . . . 71.510000000000005 110.902 -179.954 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -114.27 -38.84 4.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 61.219999999999999 110.852 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.466 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.18 -13.54 43.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 72.299999999999997 110.863 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.466 HG23 ' HG2' ' A' ' 8' ' ' ARG . 26.1 t -113.84 -44.05 4.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.193 -0.458 . . . . 75.25 111.126 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -91.02 45.12 1.23 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 70.140000000000001 111.077 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.427 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.61 -31.74 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.227 -0.442 . . . . 63.43 110.893 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.35 -11.5 32.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 74.519999999999996 110.913 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.55 0.64 5.11 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.742 -0.742 . . . . 52.409999999999997 112.506 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.463 HG13 HD23 ' A' ' 15' ' ' LEU . 8.2 p -90.84 -24.19 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.808 0.337 . . . . 64.219999999999999 111.113 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.463 HD23 HG13 ' A' ' 14' ' ' VAL . 9.6 mt -81.19 -0.1 38.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 74.140000000000001 110.914 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.463 ' O ' HD12 ' A' ' 20' ' ' ILE . . . -53.91 -21.37 16.37 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.709 -0.758 . . . . 61.340000000000003 112.478 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -107.14 -12.08 15.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.797 0.332 . . . . 75.519999999999996 111.095 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.7 -42.97 12.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 64.5 111.074 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -85.09 -22.4 28.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.28 -0.418 . . . . 73.209999999999994 110.937 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.757 HG23 ' HG3' ' A' ' 25' ' ' PRO . 24.0 mt -101.16 -18.33 6.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 73.239999999999995 111.158 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -93.03 25.78 18.19 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.686 -0.768 . . . . 74.040000000000006 112.459 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.5 -55.74 0.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.786 0.327 . . . . 44.229999999999997 111.088 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -52.01 -29.55 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.228 -0.442 . . . . 64.200000000000003 111.125 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 62.74 74.31 0.47 Allowed Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.59 0.71 . . . . 73.329999999999998 111.094 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HG3' HG23 ' A' ' 20' ' ' ILE . 54.2 Cg_endo -69.76 -16.67 37.68 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.706 2.271 . . . . 73.239999999999995 112.335 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -179.75 -33.02 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 72.030000000000001 110.896 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.467 ' NZ ' HG22 ' A' ' 20' ' ' ILE . 6.6 ptpt . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 61.399999999999999 110.927 179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.6 ptpm? . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.821 0.343 . . . . 75.0 110.913 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -146.55 107.65 4.19 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 73.150000000000006 110.948 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.52 -75.36 0.43 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 55.020000000000003 110.931 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -55.44 -28.84 56.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.44 . . . . 74.549999999999997 110.846 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.605 HD12 HH21 ' A' ' 8' ' ' ARG . 1.0 OUTLIER -61.3 -26.56 39.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 74.040000000000006 111.154 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.547 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -116.24 8.37 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.181 -0.463 . . . . 71.129999999999995 110.918 -179.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -113.36 -37.79 4.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 72.140000000000001 110.886 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.605 HH21 HD12 ' A' ' 5' ' ' ILE . 2.9 ptt85 -89.23 -14.68 35.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.177 -0.465 . . . . 62.450000000000003 110.855 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.475 HG23 ' HG2' ' A' ' 8' ' ' ARG . 45.8 t -113.04 -41.97 3.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.154 -0.475 . . . . 55.119999999999997 111.119 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -95.68 45.82 1.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.152 -0.476 . . . . 74.519999999999996 111.122 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.73 -32.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 64.120000000000005 110.961 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.97 -13.55 41.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 52.009999999999998 110.863 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -3.4 5.79 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.726 -0.75 . . . . 75.030000000000001 112.447 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.2 t -87.82 -38.64 12.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.839 0.352 . . . . 65.439999999999998 111.158 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.495 HD13 ' CD1' ' A' ' 19' ' ' LEU . 4.3 pp -82.15 0.74 39.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 70.329999999999998 110.914 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.37 -20.92 18.03 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.76 -0.733 . . . . 64.040000000000006 112.49 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.5 -15.41 15.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.832 0.348 . . . . 34.25 111.114 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.573 ' HB1' ' HD2' ' A' ' 27' ' ' LYS . . . -85.52 -42.43 14.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 75.219999999999999 111.108 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.616 HD23 ' HB2' ' A' ' 24' ' ' ALA . 0.2 OUTLIER -83.78 -23.02 31.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.238 -0.437 . . . . 54.219999999999999 110.952 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.0 mt -104.09 -15.03 8.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 111.074 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -56.35 -21.97 35.67 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.786 -0.721 . . . . 74.420000000000002 112.44 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -173.75 47.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.743 0.306 . . . . 75.420000000000002 111.123 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.1 mm 51.64 47.64 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.232 -0.44 . . . . 63.240000000000002 111.147 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.616 ' HB2' HD23 ' A' ' 19' ' ' LEU . . . 51.63 74.06 0.86 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.596 0.712 . . . . 40.439999999999998 111.113 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 -29.0 24.46 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 55.130000000000003 112.357 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.72 23.09 0.33 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 73.099999999999994 110.895 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.573 ' HD2' ' HB1' ' A' ' 18' ' ' ALA . 8.5 mmtt . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 72.430000000000007 110.926 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 36.9 mttm . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.815 0.341 . . . . 65.239999999999995 110.922 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.98 125.17 42.25 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 75.140000000000001 110.931 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.37 -67.83 0.3 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.420000000000002 110.901 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 4.3 m -62.79 -28.51 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.21 -0.45 . . . . 62.240000000000002 110.847 -179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.6 tp -60.87 -26.84 39.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.108 -0.497 . . . . 75.239999999999995 111.204 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.527 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -116.53 8.24 13.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 71.450000000000003 110.914 -179.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -112.84 -37.22 4.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 64.030000000000001 110.904 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.426 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -89.96 -14.98 32.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.131 -0.486 . . . . 75.340000000000003 110.858 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.426 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.9 t -112.79 -41.42 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 74.230000000000004 111.141 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -96.82 46.14 1.05 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 72.230000000000004 111.125 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.94 -32.41 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.209999999999994 110.921 -179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.91 -13.39 42.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.172 -0.467 . . . . 71.299999999999997 110.885 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -134.69 3.79 4.27 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.732 -0.747 . . . . 74.0 112.474 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.9 t -101.21 -25.97 3.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.879 0.371 . . . . 53.310000000000002 111.099 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.4 -1.07 39.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.197 -0.456 . . . . 72.209999999999994 110.904 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.45 -21.02 18.97 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.724 -0.75 . . . . 75.140000000000001 112.525 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -116.83 5.18 13.0 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.791 0.329 . . . . 60.100000000000001 111.11 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -98.99 -41.29 7.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 70.329999999999998 111.099 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -106.45 -19.51 13.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.181 -0.463 . . . . 71.239999999999995 110.938 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.421 ' O ' HG22 ' A' ' 20' ' ' ILE . 17.6 mt -119.65 -6.55 10.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.174 -0.466 . . . . 75.140000000000001 111.123 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -52.15 -27.46 23.24 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.744 -0.741 . . . . 52.0 112.469 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -154.33 40.62 0.47 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.781 0.324 . . . . 72.239999999999995 111.09 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.3 mm 51.7 44.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 62.399999999999999 111.141 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.46 74.23 0.83 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.575 0.702 . . . . 73.0 111.073 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.75 -48.49 0.71 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.272 . . . . 72.340000000000003 112.336 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.95 -42.51 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 72.140000000000001 110.896 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 mmmt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.224 -0.443 . . . . 75.129999999999995 110.916 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.5 mttm . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.898 0.38 . . . . 64.430000000000007 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 62.65 99.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.46 . . . . 61.109999999999999 110.873 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.76 -75.31 0.44 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 64.109999999999999 110.929 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.1 m -55.3 -28.47 53.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 72.109999999999999 110.84 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -60.63 -26.54 38.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.135 -0.484 . . . . 74.230000000000004 111.146 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.579 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.5 OUTLIER -115.97 7.08 14.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.189 -0.46 . . . . 73.109999999999999 110.931 179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -111.21 -37.38 5.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.131 -0.486 . . . . 73.230000000000004 110.902 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.611 ' HG3' HG23 ' A' ' 9' ' ' VAL . 2.2 ppt_? -89.04 -15.96 32.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 62.119999999999997 110.841 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.611 HG23 ' HG3' ' A' ' 8' ' ' ARG . 30.6 t -113.33 -41.33 3.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 52.039999999999999 111.146 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -97.65 39.99 1.18 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.206 -0.452 . . . . 42.049999999999997 111.119 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -172.05 -34.88 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 65.120000000000005 110.906 -179.99 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -83.37 -12.84 56.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 72.329999999999998 110.877 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.81 4.91 4.0 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.71 -0.757 . . . . 64.439999999999998 112.467 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.8 -25.34 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.868 0.366 . . . . 41.149999999999999 111.123 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 22.9 mt -81.88 0.4 39.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.166 -0.47 . . . . 73.5 110.905 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.31 -21.08 18.25 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 73.329999999999998 112.506 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.18 -12.52 15.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.797 0.332 . . . . 74.200000000000003 111.126 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.47 -41.59 12.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.224 -0.444 . . . . 32.200000000000003 111.068 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.48 -18.78 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 110.926 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.456 HG22 ' HG2' ' A' ' 27' ' ' LYS . 26.0 mm -105.59 -20.64 5.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 62.020000000000003 111.128 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.71 20.13 43.84 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.701 -0.762 . . . . 75.340000000000003 112.45 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -152.83 -49.35 0.1 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.752 0.31 . . . . 54.409999999999997 111.116 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.9 mm -67.6 -31.45 52.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 71.129999999999995 111.129 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 52.69 71.62 1.4 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.55 0.691 . . . . 73.129999999999995 111.059 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.452 ' HG3' HD12 ' A' ' 20' ' ' ILE . 54.0 Cg_endo -69.77 -16.89 37.72 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.671 2.247 . . . . 63.130000000000003 112.336 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -179.83 -33.2 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 62.25 110.896 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.456 ' HG2' HG22 ' A' ' 20' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.176 -0.465 . . . . 71.430000000000007 110.909 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.866 0.365 . . . . 63.25 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.3 mmtt -111.85 133.98 53.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.19 -0.459 . . . . 62.329999999999998 110.904 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.22 -63.17 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.227 -0.442 . . . . 72.030000000000001 110.903 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.97 -32.49 54.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 72.439999999999998 110.867 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.5 tp -62.18 -26.96 41.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.069 -0.514 . . . . 73.140000000000001 111.143 179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 2.4 m-85 -114.94 10.94 16.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.147 -0.479 . . . . 75.25 110.936 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -116.62 -39.01 3.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 45.509999999999998 110.897 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.402 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.4 OUTLIER -87.99 -13.82 40.72 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.134 -0.485 . . . . 74.219999999999999 110.882 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.402 HG23 ' HG2' ' A' ' 8' ' ' ARG . 61.1 t -112.75 -43.28 4.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 63.310000000000002 111.108 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.447 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -95.22 46.47 1.12 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 111.109 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.57 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 75.450000000000003 110.906 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -88.37 -12.65 42.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 60.450000000000003 110.87 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -135.04 4.1 4.18 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 70.420000000000002 112.478 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.1 t -101.05 -25.03 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.832 0.348 . . . . 74.010000000000005 111.124 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 29.9 mt -81.65 0.19 39.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 35.119999999999997 110.939 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.12 -21.18 17.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.739 -0.743 . . . . 43.130000000000003 112.499 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.76 -12.26 15.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 63.340000000000003 111.082 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.37 -43.47 12.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.47 . . . . 74.129999999999995 111.118 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -84.58 -22.68 29.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.439 . . . . 70.510000000000005 110.938 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.474 HG23 ' CG ' ' A' ' 25' ' ' PRO . 28.4 mm -100.44 -19.56 5.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.154 -0.476 . . . . 63.020000000000003 111.145 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.35 18.88 50.32 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.757 -0.735 . . . . 52.420000000000002 112.48 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -120.99 -75.53 0.59 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.79 0.328 . . . . 62.399999999999999 111.099 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.8 pt -60.16 -28.02 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.252 -0.431 . . . . 73.209999999999994 111.118 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.52 73.96 0.46 Allowed Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.598 0.713 . . . . 72.530000000000001 111.093 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' CG ' HG23 ' A' ' 20' ' ' ILE . 53.6 Cg_endo -69.75 -39.69 6.24 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.679 2.253 . . . . 74.109999999999999 112.311 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -129.6 -1.17 4.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.22 -0.445 . . . . 63.399999999999999 110.868 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.2 mmmt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 74.329999999999998 110.858 179.846 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.838 0.352 . . . . 71.129999999999995 110.906 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.604 ' O ' HD13 ' A' ' 3' ' ' LEU . 7.1 mtmp? -99.27 100.8 11.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 70.530000000000001 110.893 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.604 HD13 ' O ' ' A' ' 2' ' ' LYS . 1.9 mm? -124.86 -74.71 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.213 -0.448 . . . . 64.319999999999993 110.93 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -57.06 -27.98 62.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 53.25 110.835 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.9 tp -55.18 -29.32 22.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 71.030000000000001 111.146 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.581 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.3 OUTLIER -114.37 12.29 17.5 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 73.400000000000006 110.916 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -114.16 -38.66 4.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.1 -0.5 . . . . 73.349999999999994 110.858 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.9 ptp180 -90.84 -14.41 31.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 75.230000000000004 110.877 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.9 t -113.37 -40.58 3.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 111.126 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -94.33 45.25 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 64.329999999999998 111.118 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.24 -30.89 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.192 -0.458 . . . . 74.439999999999998 110.848 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -92.64 -14.76 27.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.436 . . . . 64.319999999999993 110.912 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -128.12 -5.15 5.3 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.735 -0.745 . . . . 64.030000000000001 112.508 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 11' ' ' LEU . 9.8 p -85.54 -29.33 6.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.887 0.375 . . . . 73.099999999999994 111.119 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.465 HD12 ' C ' ' A' ' 15' ' ' LEU . 4.2 pp -82.16 0.6 40.2 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.209 -0.45 . . . . 72.340000000000003 110.897 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.44 -20.8 18.05 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.737 -0.744 . . . . 53.020000000000003 112.516 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.09 -12.83 15.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.791 0.329 . . . . 62.210000000000001 111.084 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -88.27 -41.47 12.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 70.109999999999999 111.109 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -86.4 -18.89 30.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.251 -0.431 . . . . 73.230000000000004 110.877 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.416 HD12 ' HG3' ' A' ' 25' ' ' PRO . 26.3 mm -105.55 -20.51 5.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 71.120000000000005 111.138 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.81 20.51 41.76 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.69 -0.767 . . . . 74.349999999999994 112.496 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -153.3 -49.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.757 0.313 . . . . 73.5 111.072 179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 27.0 mm -67.64 -31.51 52.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.244 -0.435 . . . . 72.209999999999994 111.106 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.75 73.9 0.88 Allowed Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.642 0.734 . . . . 73.420000000000002 111.125 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.416 ' HG3' HD12 ' A' ' 20' ' ' ILE . 53.7 Cg_endo -69.78 -46.12 1.33 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.672 2.248 . . . . 71.209999999999994 112.335 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 3.1 ttpt -178.76 -40.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.895 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 31.0 mtmt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 53.420000000000002 110.909 179.859 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.9 mttp . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.881 0.372 . . . . 62.32 110.868 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.47 109.85 10.1 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.178 -0.464 . . . . 72.510000000000005 110.894 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 14.7 tp -168.67 123.25 0.89 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 51.509999999999998 110.929 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.8 m 71.71 2.99 4.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 72.049999999999997 110.873 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -106.92 1.33 10.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.11 -0.495 . . . . 75.120000000000005 111.185 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.61 -32.11 4.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.119 -0.491 . . . . 75.519999999999996 110.947 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.692 ' CG ' HD13 ' A' ' 11' ' ' LEU . 1.2 mt-10 -96.14 -3.74 43.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.146 -0.479 . . . . 62.340000000000003 110.873 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 5.1 tpm_? -100.11 -19.38 16.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 70.209999999999994 110.91 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.5 t -121.39 -41.59 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.162 -0.472 . . . . 74.349999999999994 111.109 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -100.69 42.42 1.12 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.449 . . . . 71.329999999999998 111.106 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.692 HD13 ' CG ' ' A' ' 7' ' ' GLU . 3.5 tt -172.94 -35.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 45.130000000000003 110.916 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.6 t80 -86.21 -14.2 44.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.901 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -127.91 -3.37 5.9 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.715 -0.755 . . . . 75.430000000000007 112.445 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.7 t -87.64 -37.87 11.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.367 . . . . 73.219999999999999 111.13 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 15' ' ' LEU . 4.3 pp -81.32 -0.03 39.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.214 -0.448 . . . . 75.140000000000001 110.896 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.4 -20.02 20.82 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 75.219999999999999 112.494 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.05 -1.09 13.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.779 0.323 . . . . 72.25 111.101 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.78 -40.69 9.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.2 -0.455 . . . . 74.400000000000006 111.16 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.18 -23.5 16.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.209999999999994 110.941 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 27.5 mt -116.97 -21.51 4.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.45 . . . . 74.239999999999995 111.119 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.25 19.24 48.05 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.69 -0.767 . . . . 62.140000000000001 112.512 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.07 -68.69 0.85 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.721 0.296 . . . . 75.030000000000001 111.081 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -62.06 -26.96 41.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.428 . . . . 75.040000000000006 111.107 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB1' ' HB2' ' A' ' 27' ' ' LYS . . . 56.3 73.79 0.78 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.603 0.715 . . . . 71.209999999999994 111.106 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.79 -19.98 35.3 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.674 2.25 . . . . 75.5 112.307 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.73 22.98 0.33 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.24 -0.436 . . . . 70.219999999999999 110.862 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.457 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 10.5 mmtt . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.252 -0.431 . . . . 61.039999999999999 110.917 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 13.6 mttm . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.856 0.36 . . . . 63.210000000000001 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -129.56 106.27 8.63 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 51.439999999999998 110.902 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.448 ' O ' ' CB ' ' A' ' 4' ' ' SER . 0.1 OUTLIER -129.54 104.28 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 73.230000000000004 110.93 179.92 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER 79.32 -44.81 0.33 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.188 -0.46 . . . . 72.200000000000003 110.852 -179.913 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.9 tp -52.98 -29.25 14.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.146 -0.479 . . . . 73.120000000000005 111.1 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -76.38 -32.31 58.5 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.457 . . . . 74.420000000000002 110.9 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -85.2 -21.5 29.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 72.340000000000003 110.88 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -91.07 -5.41 55.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.230000000000004 110.893 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 5' ' ' ILE . 94.7 t -121.67 -51.78 3.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 71.510000000000005 111.165 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -90.82 46.38 1.32 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.14 -0.482 . . . . 73.140000000000001 111.063 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -177.24 -34.44 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 65.349999999999994 110.95 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -93.2 -11.75 31.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.148 -0.478 . . . . 74.540000000000006 110.909 179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.29 -0.71 5.4 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.778 -0.725 . . . . 72.430000000000007 112.508 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.623 HG13 HD23 ' A' ' 15' ' ' LEU . 8.3 p -88.08 -23.32 6.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.945 0.402 . . . . 72.120000000000005 111.164 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 HD23 HG13 ' A' ' 14' ' ' VAL . 8.0 mt -80.91 -0.31 38.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 54.25 110.889 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.08 -20.41 20.29 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.722 -0.751 . . . . 73.129999999999995 112.52 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.64 -0.42 13.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.826 0.346 . . . . 64.030000000000001 111.13 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.67 -40.74 9.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 70.109999999999999 111.099 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.43 -20.71 17.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 53.119999999999997 110.927 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.758 HG22 ' HD2' ' A' ' 27' ' ' LYS . 2.0 mp -116.72 -23.17 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.199 -0.455 . . . . 64.530000000000001 111.172 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.87 19.08 47.75 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.741 -0.743 . . . . 62.340000000000003 112.511 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.02 -64.79 0.9 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.713 0.292 . . . . 44.329999999999998 111.119 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pt -59.68 -26.53 35.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.232 -0.44 . . . . 65.329999999999998 111.129 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.43 73.98 0.54 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.608 0.718 . . . . 72.219999999999999 111.087 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.717 ' HG3' HG23 ' A' ' 20' ' ' ILE . 53.6 Cg_endo -69.8 -45.62 1.5 Allowed 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.732 2.288 . . . . 72.310000000000002 112.323 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.42 22.9 0.35 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 72.430000000000007 110.908 179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.758 ' HD2' HG22 ' A' ' 20' ' ' ILE . 32.2 mtpt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.265 -0.425 . . . . 73.400000000000006 110.883 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.849 0.357 . . . . 55.100000000000001 110.907 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 13.7 mttp -142.74 143.66 32.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 64.340000000000003 110.891 179.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -176.43 -62.65 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 54.039999999999999 110.946 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 2.7 m -49.78 -51.69 37.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.465 . . . . 72.109999999999999 110.87 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.1 mm -54.14 -44.81 65.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 70.340000000000003 111.146 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.68 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -80.89 -1.26 42.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 110.862 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -101.45 -33.13 10.1 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 72.230000000000004 110.862 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -87.63 -12.56 45.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.16 -0.473 . . . . 74.329999999999998 110.872 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 47.8 t -113.28 -47.65 5.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.129999999999995 111.086 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.68 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -90.91 45.96 1.29 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.209999999999994 111.127 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.453 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.98 -32.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 61.009999999999998 110.91 -179.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -91.51 -10.84 39.28 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.214 -0.448 . . . . 70.239999999999995 110.847 179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.01 0.4 5.3 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.72 -0.752 . . . . 71.540000000000006 112.469 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.8 t -89.65 -20.07 7.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.885 0.374 . . . . 73.25 111.162 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.79 -1.97 33.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 74.230000000000004 110.928 179.943 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.54 -19.63 20.14 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.762 -0.732 . . . . 64.299999999999997 112.501 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.58 -1.46 14.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.813 0.34 . . . . 65.109999999999999 111.094 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.15 -39.72 9.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.198 -0.456 . . . . 70.439999999999998 111.151 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.36 -23.89 15.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 64.150000000000006 110.923 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.8 mt -117.31 -21.31 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 64.319999999999993 111.155 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.19 19.09 48.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.764 -0.732 . . . . 52.140000000000001 112.463 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -124.96 -70.32 0.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.728 0.299 . . . . 71.549999999999997 111.113 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pt -56.91 -30.8 34.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 54.530000000000001 111.154 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.32 73.72 0.48 Allowed Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.532 0.682 . . . . 55.350000000000001 111.09 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 -29.96 23.19 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.69 2.26 . . . . 73.540000000000006 112.339 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.7 22.97 0.33 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 72.519999999999996 110.914 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 7.9 mmtt . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 73.530000000000001 110.874 179.917 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.887 0.375 . . . . 55.210000000000001 110.938 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -125.06 137.29 54.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 60.25 110.906 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -166.31 -74.2 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 72.040000000000006 110.93 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.6 m -53.37 -33.67 54.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.836 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.428 ' O ' HG23 ' A' ' 9' ' ' VAL . 10.5 tp -56.95 -23.83 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 75.209999999999994 111.175 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -112.57 -23.13 10.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.128 -0.487 . . . . 74.310000000000002 110.923 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -78.28 -27.28 47.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.138 -0.483 . . . . 70.530000000000001 110.927 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 30.8 mtm-85 -83.55 -44.44 14.64 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 70.420000000000002 110.896 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 5' ' ' ILE . 93.9 t -50.94 -27.35 5.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 54.43 111.092 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -89.0 31.94 0.84 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.446 . . . . 62.399999999999999 111.072 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.72 -34.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.247 -0.433 . . . . 71.299999999999997 110.899 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -78.51 -16.94 56.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.454 . . . . 72.530000000000001 110.925 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.24 2.24 4.64 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.81 -0.71 . . . . 65.230000000000004 112.503 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.2 t -99.92 -25.15 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.846 0.355 . . . . 71.340000000000003 111.116 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.634 ' HB3' HD23 ' A' ' 19' ' ' LEU . 24.7 mt -81.87 0.46 39.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.468 . . . . 73.420000000000002 110.91 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.93 -19.43 22.21 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 71.540000000000006 112.46 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -115.55 1.07 13.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.737 0.304 . . . . 74.319999999999993 111.083 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.8 -42.53 8.29 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 71.120000000000005 111.081 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 15' ' ' LEU . 0.7 OUTLIER -97.92 -22.2 16.45 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.255 -0.429 . . . . 70.540000000000006 110.941 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.625 ' CD1' HD12 ' A' ' 19' ' ' LEU . 26.5 mm -116.75 -20.02 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 73.420000000000002 111.121 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.29 18.84 50.28 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.724 -0.75 . . . . 72.209999999999994 112.461 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -127.35 -62.27 1.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.75 0.31 . . . . 74.299999999999997 111.099 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.4 pt -68.42 -24.99 30.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.228 -0.442 . . . . 62.530000000000001 111.144 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.03 73.9 0.86 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.568 0.699 . . . . 20.0 111.067 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 -26.46 27.6 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.68 2.253 . . . . 74.430000000000007 112.351 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.74 23.04 0.33 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 75.450000000000003 110.896 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.8 mmtt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.214 -0.448 . . . . 71.030000000000001 110.949 179.801 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 18.5 mttt . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.82 0.343 . . . . 75.329999999999998 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -131.08 170.91 13.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.237 -0.438 . . . . 74.549999999999997 110.883 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.462 HD23 ' N ' ' A' ' 4' ' ' SER . 0.4 OUTLIER -179.23 -74.48 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.207 -0.451 . . . . 65.409999999999997 110.916 179.873 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.462 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.5 OUTLIER -54.04 -33.9 58.57 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 64.340000000000003 110.825 -179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.4 tp -63.38 -27.15 42.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 74.230000000000004 111.177 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -112.64 8.32 19.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.114 -0.494 . . . . 63.119999999999997 110.946 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -113.87 -38.6 4.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 64.409999999999997 110.875 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.42 ' HG2' HG23 ' A' ' 9' ' ' VAL . 9.6 ptt180 -87.12 -13.92 42.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.13 -0.486 . . . . 64.349999999999994 110.882 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.42 HG23 ' HG2' ' A' ' 8' ' ' ARG . 47.6 t -113.62 -43.96 4.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 111.156 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.568 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -92.28 45.42 1.2 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 75.540000000000006 111.068 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -179.91 -32.52 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.265 -0.425 . . . . 72.209999999999994 110.94 -179.992 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -90.74 -11.45 39.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.207 -0.451 . . . . 61.240000000000002 110.889 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.25 -0.41 5.47 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 42.130000000000003 112.473 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 57.3 t -88.43 -19.83 7.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.858 0.361 . . . . 55.140000000000001 111.114 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 16' ' ' GLY . 0.6 OUTLIER -100.55 -1.89 34.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 75.420000000000002 110.893 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.405 ' N ' HD12 ' A' ' 15' ' ' LEU . . . -55.67 -19.47 20.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.749 -0.739 . . . . 73.450000000000003 112.517 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -113.43 -1.43 14.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.854 0.359 . . . . 52.439999999999998 111.128 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -95.7 -39.04 10.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.225 -0.443 . . . . 64.420000000000002 111.113 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.42 -21.35 17.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.188 -0.46 . . . . 63.43 110.918 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.0 mp -117.28 -23.86 3.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 61.119999999999997 111.139 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.85 19.11 47.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.75 -0.738 . . . . 64.420000000000002 112.514 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -151.07 -51.81 0.13 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.728 0.299 . . . . 72.299999999999997 111.106 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 43.3 mm -62.16 -26.9 41.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.234 -0.439 . . . . 74.140000000000001 111.164 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 53.75 66.68 4.24 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.618 0.723 . . . . 50.009999999999998 111.107 179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.71 58.2 1.51 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.689 2.26 . . . . 64.219999999999999 112.387 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.7 ptmt 175.49 -51.92 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 72.219999999999999 110.882 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.4 mttt . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 72.25 110.878 179.856 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 17.7 ttmt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.899 0.381 . . . . 73.310000000000002 110.932 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 46.2 mttt -122.91 143.07 50.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.154 -0.475 . . . . 65.019999999999996 110.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -174.92 -65.27 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 53.240000000000002 110.901 179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.2 m -53.82 -33.3 55.73 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 71.219999999999999 110.841 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.417 HG23 ' CG ' ' A' ' 6' ' ' TYR . 8.3 tp -61.85 -27.81 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.158 -0.474 . . . . 74.319999999999993 111.119 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.417 ' CG ' HG23 ' A' ' 5' ' ' ILE . 33.2 m-85 -114.06 12.79 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 74.140000000000001 110.892 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -118.53 -40.39 2.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.118 -0.492 . . . . 65.439999999999998 110.871 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -87.28 -12.8 45.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 54.210000000000001 110.833 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG23 ' HG2' ' A' ' 8' ' ' ARG . 21.8 t -113.98 -43.95 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 75.200000000000003 111.119 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -92.69 44.62 1.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 62.530000000000001 111.085 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.405 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.64 -31.93 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.228 -0.442 . . . . 74.540000000000006 110.906 -179.98 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -92.78 -11.54 33.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 75.519999999999996 110.897 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.655 ' O ' ' HB3' ' A' ' 18' ' ' ALA . . . -111.09 -18.16 8.43 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.81 -0.709 . . . . 63.530000000000001 112.494 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.738 HG12 ' H ' ' A' ' 16' ' ' GLY . 73.6 t -87.4 -66.98 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 52.530000000000001 111.118 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt 45.98 30.51 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 72.319999999999993 110.921 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.738 ' H ' HG12 ' A' ' 14' ' ' VAL . . . 50.71 29.24 18.19 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.713 -0.756 . . . . 73.420000000000002 112.498 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -134.61 -74.89 0.47 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 54.210000000000001 111.094 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.655 ' HB3' ' O ' ' A' ' 13' ' ' GLY . . . -51.21 -52.25 46.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 70.25 111.078 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.671 ' HB2' HG13 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.26 -28.45 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.252 -0.431 . . . . 73.510000000000005 110.942 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.627 HD12 ' O ' ' A' ' 16' ' ' GLY . 68.7 mt -88.0 -20.34 7.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.213 -0.448 . . . . 71.310000000000002 111.121 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -90.83 17.84 53.26 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 40.439999999999998 112.462 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -123.6 -74.96 0.6 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.74 0.305 . . . . 60.109999999999999 111.142 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.3 pt -56.39 -27.36 24.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.452 . . . . 72.0 111.143 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 57.12 73.49 0.78 Allowed Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.59 0.71 . . . . 63.439999999999998 111.114 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.82 -31.27 20.57 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.658 2.239 . . . . 64.299999999999997 112.37 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -156.73 23.05 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.18 -0.463 . . . . 71.439999999999998 110.866 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 6.4 mmpt? . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.245 -0.434 . . . . 74.099999999999994 110.883 179.846 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 1.1 mtpt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.873 0.368 . . . . 74.150000000000006 110.943 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.0 mtpp 63.48 169.68 0.15 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 74.439999999999998 110.886 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.7 tt 73.76 -66.27 0.31 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 75.120000000000005 110.923 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.4 m -56.16 -21.48 23.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 74.510000000000005 110.857 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 tp -56.22 -27.29 23.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 70.510000000000005 111.143 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 1.2 m-85 -120.01 10.06 11.38 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 74.5 110.912 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.79 -32.14 6.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 52.210000000000001 110.891 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.471 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -94.08 -19.81 20.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.129 -0.487 . . . . 74.299999999999997 110.91 -179.923 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.471 HG23 ' HG2' ' A' ' 8' ' ' ARG . 31.1 t -112.73 -36.69 2.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 72.299999999999997 111.128 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -101.94 45.48 0.96 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 71.239999999999995 111.076 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -179.69 -32.05 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 75.25 110.894 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.66 -15.31 42.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 62.039999999999999 110.902 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -133.78 2.82 4.51 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.762 -0.732 . . . . 62.039999999999999 112.477 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 90.6 t -99.77 -24.65 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.871 0.367 . . . . 53.520000000000003 111.101 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 55.9 mt -81.67 0.22 39.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 75.450000000000003 110.899 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.5 -20.11 21.97 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.763 -0.732 . . . . 74.120000000000005 112.465 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.38 -0.5 13.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.329 . . . . 61.200000000000003 111.095 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.02 -40.96 8.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 63.43 111.091 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.59 -23.33 16.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.224 -0.443 . . . . 64.219999999999999 110.937 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.808 HG22 ' HD3' ' A' ' 27' ' ' LYS . 26.4 mt -117.08 -19.56 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 111.141 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -92.81 25.71 17.97 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.764 -0.732 . . . . 74.099999999999994 112.489 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -145.45 -58.43 0.33 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.738 0.304 . . . . 73.439999999999998 111.124 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.3 pt -55.2 -29.94 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.206 -0.452 . . . . 75.329999999999998 111.095 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 63.86 74.87 0.41 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.593 0.711 . . . . 64.530000000000001 111.088 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.71 ' HG3' HG23 ' A' ' 20' ' ' ILE . 53.9 Cg_endo -69.77 -34.11 15.2 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 74.530000000000001 112.345 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 11.6 pttt -179.79 -32.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.235 -0.439 . . . . 71.319999999999993 110.957 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.808 ' HD3' HG22 ' A' ' 20' ' ' ILE . 11.4 ptmt . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 45.229999999999997 110.891 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 6.8 tttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.846 0.355 . . . . 62.020000000000003 110.866 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 110.89 8.76 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 75.319999999999993 110.892 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -169.6 123.35 0.77 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 61.210000000000001 110.913 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 71.17 2.54 4.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.236 -0.438 . . . . 73.340000000000003 110.855 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.17 0.53 10.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 73.319999999999993 111.124 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.592 ' O ' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -116.91 -24.36 7.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.473 . . . . 74.010000000000005 110.91 -179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.95 -26.17 20.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 74.120000000000005 110.851 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 ptm180 -88.49 -14.22 38.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 74.099999999999994 110.863 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 26.1 t -112.7 -49.53 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 60.350000000000001 111.074 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 6' ' ' TYR . . . -89.82 46.85 1.4 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 111.077 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.435 ' HA ' HG12 ' A' ' 14' ' ' VAL . 0.2 OUTLIER 179.34 -32.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.178 -0.464 . . . . 71.340000000000003 110.935 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.42 -11.08 33.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 61.140000000000001 110.899 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -131.66 0.87 5.1 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.764 -0.731 . . . . 32.43 112.523 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.501 HG13 HD23 ' A' ' 15' ' ' LEU . 7.7 p -91.08 -23.65 5.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.853 0.358 . . . . 73.099999999999994 111.143 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.733 ' HB3' HD23 ' A' ' 19' ' ' LEU . 8.4 mt -82.04 0.89 38.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 74.129999999999995 110.958 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.77 -19.45 21.09 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.753 -0.737 . . . . 71.540000000000006 112.527 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -112.39 -7.85 13.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.743 0.306 . . . . 74.019999999999996 111.097 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -96.4 -44.5 7.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.449 . . . . 71.510000000000005 111.13 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.733 HD23 ' HB3' ' A' ' 15' ' ' LEU . 3.7 mm? -81.05 -20.23 42.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 64.109999999999999 110.914 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.1 tt -65.55 -27.42 41.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 53.539999999999999 111.126 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -89.72 18.06 49.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.723 -0.751 . . . . 72.219999999999999 112.473 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -140.61 -61.38 0.5 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.761 0.315 . . . . 75.400000000000006 111.083 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 74.2 mt -52.94 -28.22 13.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.239 -0.437 . . . . 75.329999999999998 111.127 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 61.34 77.11 0.37 Allowed Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.556 0.694 . . . . 74.329999999999998 111.097 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.76 -33.19 17.08 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.672 2.248 . . . . 54.43 112.357 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.66 -33.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.24 -0.436 . . . . 74.549999999999997 110.902 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.2 ptmt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.249 -0.432 . . . . 71.25 110.846 179.88 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.844 0.354 . . . . 74.310000000000002 110.869 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 5.4 mtpt -115.38 101.8 9.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 110.902 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.76 -75.12 0.48 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.289 -0.414 . . . . 72.439999999999998 110.873 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 3.7 m -55.23 -31.53 61.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.192 -0.458 . . . . 74.230000000000004 110.816 -179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' HG23 ' A' ' 9' ' ' VAL . 6.5 tp -53.33 -29.6 16.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.141 -0.481 . . . . 73.319999999999993 111.117 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.46 -10.87 15.23 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.224 -0.443 . . . . 71.030000000000001 110.941 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -87.51 -27.41 22.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.117 -0.492 . . . . 63.539999999999999 110.91 179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.07 -41.98 14.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 61.539999999999999 110.856 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 5' ' ' ILE . 86.5 t -55.51 -22.52 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 74.430000000000007 111.132 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -8.36 35.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.216 -0.447 . . . . 63.340000000000003 111.138 179.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.5 tp -134.91 -32.92 0.95 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 71.209999999999994 110.927 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -88.74 -18.11 28.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.188 -0.46 . . . . 74.150000000000006 110.87 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -120.83 -17.98 4.06 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.777 -0.725 . . . . 53.009999999999998 112.48 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 9.9 p -63.93 -24.0 34.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 63.32 111.128 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -99.4 -1.23 39.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 75.310000000000002 110.931 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.95 -20.05 17.77 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.748 -0.739 . . . . 51.109999999999999 112.485 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -105.78 -12.28 15.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.832 0.348 . . . . 45.039999999999999 111.073 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -87.69 -42.82 12.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.218 -0.446 . . . . 72.430000000000007 111.069 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.2 mt -84.9 -22.32 29.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.224 -0.444 . . . . 42.119999999999997 110.9 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.6 mm -101.2 -19.43 5.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 53.32 111.134 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -91.29 18.65 51.04 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 34.32 112.494 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -129.54 -67.42 0.76 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.744 0.307 . . . . 54.130000000000003 111.116 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 73.0 mt -56.92 -28.34 28.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 42.520000000000003 111.138 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 27' ' ' LYS . . . 58.17 71.09 1.09 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.559 0.695 . . . . 74.129999999999995 111.118 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.83 -19.42 35.83 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.663 2.242 . . . . 64.549999999999997 112.304 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -156.77 23.07 0.33 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 72.409999999999997 110.894 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 16.7 mmtm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 75.530000000000001 110.853 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.847 0.356 . . . . 73.219999999999999 110.909 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 8.5 pttt -145.72 111.96 5.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 64.519999999999996 110.932 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.6 123.24 0.64 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 74.439999999999998 110.953 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 72.43 0.2 3.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 74.099999999999994 110.886 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -120.67 -1.55 8.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.483 . . . . 70.549999999999997 111.115 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 27.1 p90 -108.49 -25.97 10.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.183 -0.462 . . . . 61.229999999999997 110.893 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -92.14 -21.98 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.115 -0.493 . . . . 74.120000000000005 110.937 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -88.24 -13.37 41.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 73.25 110.85 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 22.0 t -111.9 -52.74 5.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 73.319999999999993 111.139 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' O ' HD12 ' A' ' 11' ' ' LEU . . . -88.92 48.13 1.59 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 71.209999999999994 111.07 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 10' ' ' ALA . 0.2 OUTLIER 179.66 -32.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 75.129999999999995 110.92 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -91.37 -10.75 40.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.454 . . . . 74.230000000000004 110.868 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -130.92 0.31 5.32 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.7 -0.762 . . . . 72.129999999999995 112.461 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -89.44 -19.83 7.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.835 0.35 . . . . 55.240000000000002 111.097 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.745 HD13 HD23 ' A' ' 19' ' ' LEU . 0.6 OUTLIER -100.71 0.65 39.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.454 . . . . 55.140000000000001 110.885 179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.64 -17.35 26.79 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.755 -0.736 . . . . 51.549999999999997 112.467 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -109.86 -9.84 14.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 73.230000000000004 111.085 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -92.54 -44.31 8.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.108 179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.745 HD23 HD13 ' A' ' 15' ' ' LEU . 1.3 pp -79.77 -23.6 42.09 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 52.409999999999997 110.918 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.3 tt -59.29 -23.35 24.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 73.439999999999998 111.117 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -83.76 5.84 76.87 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.739 -0.743 . . . . 33.130000000000003 112.516 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.09 -75.53 0.62 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.756 0.312 . . . . 63.240000000000002 111.082 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 pt -63.87 -25.36 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.183 -0.462 . . . . 61.039999999999999 111.143 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' HB1' ' HB2' ' A' ' 27' ' ' LYS . . . 53.14 73.31 0.95 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.628 0.727 . . . . 51.539999999999999 111.118 179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.72 -19.19 36.65 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.704 2.27 . . . . 71.230000000000004 112.307 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.69 22.94 0.33 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 72.329999999999998 110.914 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' HB2' ' HB1' ' A' ' 24' ' ' ALA . 8.7 mmmt . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 72.140000000000001 110.887 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 2.0 mptt . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.807 0.337 . . . . 74.540000000000006 110.895 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -152.24 109.6 3.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.217 -0.447 . . . . 50.119999999999997 110.907 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -167.0 128.54 1.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 75.340000000000003 110.9 179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 1.4 m 74.99 -4.7 2.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.194 -0.457 . . . . 13.51 110.867 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -106.78 4.26 10.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 75.310000000000002 111.12 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -116.41 -27.14 6.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.156 -0.474 . . . . 74.109999999999999 110.911 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.16 -24.42 18.25 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.096 -0.502 . . . . 74.420000000000002 110.886 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.2 mtt-85 -90.97 -6.62 53.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 74.209999999999994 110.889 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.5 t -119.33 -50.37 3.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.173 -0.467 . . . . 74.120000000000005 111.11 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -97.1 45.12 1.04 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 75.140000000000001 111.08 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -173.56 -35.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.46 . . . . 75.140000000000001 110.896 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -84.64 -11.09 56.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 71.209999999999994 110.869 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -136.93 6.0 3.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.74 -0.743 . . . . 74.010000000000005 112.501 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -105.42 -25.82 3.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.878 0.371 . . . . 71.120000000000005 111.117 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 21.4 mt -81.97 0.54 39.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 74.319999999999993 110.916 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -54.25 -21.08 17.8 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.76 -0.733 . . . . 43.530000000000001 112.472 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.88 -14.12 15.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 73.530000000000001 111.102 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.502 ' HB1' ' HG3' ' A' ' 27' ' ' LYS . . . -86.19 -43.22 13.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 52.340000000000003 111.104 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -83.76 -22.87 31.76 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 73.510000000000005 110.917 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 25.4 mm -102.09 -17.2 7.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.465 . . . . 23.420000000000002 111.125 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -58.16 -19.8 40.35 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.718 -0.754 . . . . 73.409999999999997 112.501 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -178.33 48.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.717 0.294 . . . . 73.530000000000001 111.086 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.5 mm 51.72 46.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.232 -0.44 . . . . 62.119999999999997 111.145 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 51.55 73.9 0.89 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.597 0.713 . . . . 54.039999999999999 111.077 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 -48.4 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.716 2.278 . . . . 45.329999999999998 112.301 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mtmt -156.95 23.14 0.32 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 61.310000000000002 110.935 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.502 ' HG3' ' HB1' ' A' ' 18' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 110.886 179.89 . . . . . . . . 2 2 . 1 stop_ save_